Antibody Bank (Kato's Lab; Tohoku University)

Antibody Bank
(Kato's Lab; Tohoku University)

mAb list (target)
ACKR1/ ACKR2/ ACKR3/ ACKR4/ ACKR5/ ATRX/ BAPtag/ CA4/ CART (CD19/ GPC3/ HER2/ PDPN/ PODXL)/ CasMab (PDPN/ PODXL/ CD44s/ CD44v6/ EpCAM/ TROP2/ EGFR/ HER2/ HER3)/ cat protein (cMET/ cPDPN)/ CCR1/ CCR2/ CCR3/ CCR4/ CCR5/ CCR6/ CCR7/ CCR8/ CCR9/ CCR10/ CD10/ CD19/ CD20 (rituximab; obinutuzumab; ofatumumab)/ CD39/ CD44s/ CD44v3/ CD44v4/ CD44v5/ CD44v6 (bivatuzumab)/ CD44v7/ CD44v8/ CD44v9/ CD44v10/ CD73/ CD133/ CD271/ CD273/ CD274/ CD276/ CDH1/ CDH2/ CDH3/ CDH4/ CDH5/ CDH6/ CDH7/ CDH8/ CDH9/ CDH10/ CDH11/ CDH12/ CDH13/ CDH15/ CDH16/ CDH17/ CDH18/ CDH19/ CDH20/ CDH21/ CDH22/ CDH23/ CDH24/ CDH25/ CXCR1/ CXCR2/ CXCR3/ CXCR4/ CXCR5/ CXCR6/ CXCR7/ CX3CR1/ DGK/ dog protein (dPDPN/ dHER2/ dEGFR/ dPD-L1)/ EGFR (cetuximab; panitumumab)/ EpCAM/ EphA1/ EphA2/ EphA3/ EphA4/ EphA5/ EphA6/ EphA7/ EphA8/ EphA10/ EphB1/ EphB2/ EphB3/ EphB4/ EphB6/ GM3/ GPC1/ GPC2/ GPC3/ GPC4/ GPC5/ GPC6/ HER2 (pertuzumab; trastuzumab)/ HER3 (patritumab)/ HER4/ HGF/ Histag/ IDH/ isotype control/ KLRG1/ LPtag/ MAPtag/ MBPtag/ mCasMab (mEGFR/ mHER2)/ PAtag/ PD-L1/ PD-L2/ PODXL/ PDPN (mouse; rat; rabbit; dog; bovine; cat; tiger; horse; pig; goat; alpaca; Tas_devil; bear; whale; sheep; sea_lion; elephant; ferret; hamster; giraffe; panda; rhino; hippo)/ RAPtag/ RdRP/ RIEDLtag/ SARS-CoV-2 (N/ S2/ bispecific/ bebtelovimab; cilgavimab; casirivimab; bamlanivimab)/ TERT/ TIGIT/ TROP2 (datopotamab; sacituzumab)/ XCR1

--> company (clone)
--> Kato' lab in Tohoku University Graduate School of Medicine
--> YouTube

Peptide tag system

PA tag NZ-1	Character	Application	Ref	Gene cloning	Company
anti-PA tag mAb NZ-1; rat IgG2a, lambda	PAtag: GVAMPGAEDDVV; 12 amino acid; trademark: No. 5671624; ref: Nature; Nature; Commu biol	Purification, IP, IHC, WB, FACS	PEP2014; JCS2016 PS2019; AC2021 Sci2022	done	APRO wako
anti-PA tag mAb NZ-27; human IgG1, lambda	PAtag: GVAMPGAEDDVV; 12 amino acid; trademark: No. 5671624; from AMED_PDIS project	Purification, IP, IHC, WB, FACS	JBC2023	done
anti-PA14 tag mAb NZ-1; rat IgG2a, lambda	PA14 tag: EGGVAMPGAEDDVV; from AMED_SentanBio	Purification, IP, IHC, WB, FACS	PA14 tag system hGH-fusion Fab	done	APRO
anti-PA16 tag mAb NZ-1; rat IgG2a, lambda	PA16 tag: GLEGGVAMPGAEDDVV; from AMED_SentanBio	Purification, IP, IHC, WB, FACS	C44Mab5; PMab202; PMab210; PMab213; PMab219; PMab233	done	APRO
MAP tag PMab-1	Character	Application	Ref	Gene cloning	Company
anti-MAP tag mAb PMab-1: rat IgG2a, kappa--> PAtag	MAPtag (GDGMVPPGIEDK; 12 amino acids); trademark: No. 5988384; from AMED_KakushinBio; press release	Purification, IP, IHC, WB, FACS	MAB2016 BBREP2018 JB2020	done	APRO; AA; abcam; Nov; Merck; BL
anti-MAP16 tag mAb (PMab-1; rat IgG2a, kappa)	MAP16 tag: PGTGDGMVPPGIEDKI; 16 amino acids; from AMED_Tousa	Purification, IP, IHC, WB, FACS	PMab-235 PMab-44_goat	done
RAP tag PMab-2	Character	Application	Ref	Gene cloning	Company
anti-RAP tag mAb (PMab-2; mouse IgG1, kappa)--> PAtag	RAP tag: DMVNPGLEDRIE; 12 amino acids; from AMED_KakushinBio	Purification, IP, IHC, WB, FACS	MAB2017 FPS2020 PP2021	done	APRO; AA; abcam Merck; BL
anti-RAP14 tag mAb (double tag) (PMab-2; LpMab-7)	RAP14 tag (DMVNPGLEDRIEDL; 14 amino acids); from AMED_Tousa	Purification, IP, IHC, WB, FACS	PMab44; PMab256; PDF; PMab253	done
anti-RAP16 tag mAb (PMab-2; mouse IgG1, kappa)	RAP16 (GPGDDMVNPGLEDRIE; 16 amino acids); from AMED_SentanBio	Purification, IP, IHC, WB, FACS	PMab-225_alpaca PMab-225_epitope PMab-44_alpaca	done
RIEDL tag LpMab-7	Character	Application	Ref	Gene cloning	Company
anti-RIEDL tagmAb (LpMab-7; mouse IgG1, kappa)-->PAtag	RIEDLtag (RIEDL; 5 amino acids): from AMED_SentanBio	Purification, IP, IHC, WB, FACS	RIEDL; PMab237 (1); PMab237 (2); C44-5; C44-46; E134; E51	done	abcam
MBP tag TMab-2	Character	Application	Ref	Gene cloning	Company
anti-MBP tag mAb (TMab-2; rat IgG2b, kappa)	specific for maltose-binding protein	IHC, WB	PubMed	done	APRO
anti-MBP tag mAb (YM-2;rat IgG2b, kappa)	specific for maltose-binding protein	IHC, WB	PubMed	done	BioLegend
BAP tag PMab-44	Character	Application	Ref	Gene cloning	Company
anti-BAP tagmAb (PMab-44; mouse IgG1, kappa)--> PAtag	BAP tag(EKTTLGVEDYTTTPAA; 16 amino acids); from AMED_BINDS_SentanBio	Purification, IP, IHC, WB, FACS	PMab247 PMab241	done	APRO Zenogen
LP tag LpMab-17	Character	Application	Ref	Gene cloning	Company
anti-LP tag mAb (LpMab-17; mouse IgG1, kappa)-->PAtag	LPtag (NSVTGIRIEDLPTSES; 16 amino acids); from AMED_BINDS_SentanBio	Purification, IP, IHC, WB, FACS	PMab52 PMab231	done	BD Merck
His tag HisMab-1	Character	Application	Ref	Gene cloning	Company
anti-His tag (HisMab-1;mouse IgG2b, kappa)-->PAtag	His tag (HHHH; 4 amino acids); from AMED_SentanBio; Kd: 4.4 x 10^-9 M	Purification, IP, IHC, WB, FACS	C20Mab60 Rituximab C20Mab11	done	APRO
anti-His tag (HisMab-1-hG1; human IgG1, kappa)	His tag (HHHH; 4 amino acids); from AMED_SentanBio	Purification, IP, IHC, WB, FACS		done
anti-His tag (HisMab-1-scFv-mG2a; mouse IgG2a)	scFv of HisMab-1; Kd: 6.6 x 10^-9 M	IHC, WB, FACS		done

Back to list

Isotype control

antibody (mouse)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 mAb (CvMab-62; mouse IgG1, kappa)	specific for SARS-CoV-2 S2	ELISA isotype control of mouse IgG1	CvMab-62	done
anti-tiger PDPN mAb (PMab-231-f; mouse IgG2a, kappa)	defucosylation of PMab-231	isotype control of mouse IgG2a in vivo	250_in vivo	done	zenogen
anti-hamPDPN mAb (281-mG2a-f; mouse IgG2a, kappa)	defucocylated 281-mG2a	isotype control of mouse IgG2a in vivo	H2Mab-214 H2Mab-77	done
anti-RdRP mAb (RdMab-20; mouse IgG2b, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP	ELISA, WB isotype control of mouse IgG2b	RdMab-20	done
anti-RdRP mAb (RdMab-13; mouse IgM, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP	ELISA, WB isotype control of mouse IgM	RdMab-13	done
antibody (rat)	Character	Application	Ref	Gene cloning	Company
anti-mTERT mAb (TmMab-1; rat IgG1, kappa)	specific for mTERT	ELISA, WB isotype control of rat IgG1		done
anti-mTERT mAb (TmMab-2; rat IgG2a, kappa)	specific for mTERT	ELISA isotype control of rat IgG2a		done
anti-IDH1 mAb(RcMab-1; rat IgG2a, kappa)	specific for IDH1	IHC, WB isotype control of rat IgG2a	RcMab-1	done	abcam CST MBL
anti-IDH2-R172K mAb (KMab-1; rat IgG2b, kappa)	specific for IDH2-R172K	IHC, WB isotype control of rat IgG2b	KMab-1	done	abcam MBL
antibody (human)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 mAb (humCvMab-62; human IgG1, kappa)	specific for SARS-CoV-2 S2	ELISA isotype control of human IgG1		done

Back to list

Chemokine receptor (summary)

mouse CCR1 (CD191)	Character --> anti-human CCR1	Application	Ref	Gene cloning
anti-mouse CCR1 mAb (C1Mab-1; rat IgG2b, lambda)	CBIS method; Kd: 1.5 x 10^-8 M ref: clone S15040E (BioLegend); rat IgG2b; Kd: 3.5 x 10^-8 M; no mAb from BD (summary)	FACS, WB		done
anti-mouse CCR1 mAb (C1Mab-2; rat IgG2b, lambda)	CBIS method Kd: 3.9 x 10^-9 M	FACS, WB		done
anti-mouse CCR1 mAb (C1Mab-5; rat IgG2b, lambda)	CBIS method Kd: 1.2 x 10^-8 M	FACS, WB		done
anti-mouse CCR1 mAb (C1Mab-6; rat IgG2b, kappa)	CBIS method Kd: 3.9 x 10^-9 M	FACS, WB	C1Mab-6	done

Back to list

mouse CCR2 (CD192)	Character --> anti-human CCR2	Application	Ref	Gene cloning	Company
anti-mouse CCR2 mAb (C2Mab-6; rat IgG1, kappa)	ref: clone EPR20844-15 (abcam); rabbit IgG ref: clone 475301 (BD); rat IgG2b ref: clone SA203G11 (BioLegend); rat IgG2b	FACS, WB, ICC	C2Mab-6 epitope (summary)	done	BD

Back to list

mouse CCR3 (CD193)	Character --> anti-human CCR3	Application	Ref	Gene cloning
anti-mouse CCR3 mAb(C3Mab-2; rat IgG2b, kappa)	specific for mouse CCR3; established by CBIS method (summary)	FACS	C3Mab-2 ICC	done
anti-mouse CCR3 mAb (C3Mab-3; rat IgG2a, kappa0	specifc mouse CCR3; established by CBIS method	FACS	C3Mab-3 epitope	done
anti-mouse CCR3 mAb (C3Mab-4; rat IgG2a, kappa)	specific mouse CCR3; established by CBIS method	FACS	epitope	done
anti-mouse CCR3 mAb (C3Mab-6; rat IgG1, kappa)	specific mouse CCR3; peptide immunization	FACS	C3Mab-6 epitope	done
anti-mouse CCR3 mAb (C3Mab-7; rat IgG1, kappa)	specific mouse CCR3; peptide immunization	FACS	C3Mab-7 epitope-1 epitope-2	done

Back to list

mouse CCR4 (CD194)	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR4 mAb (C4Mab-1; rat IgG1, kappa)	specific for mouse CCR4; peptide immunization 2G12 (BioLegend); hamster IgG no mAb from BD (summary)	FACS	C4Mab-1 epitope	done
anti-mouse CCR4 mAb (C4Mab-1-mG2a-f; mIgG2a,k)	specific for mouse CCR4	FACS		done

Back to list

mouse CCR5 (CD195)	Character	Application	Ref	Gene cloning
anti-mouse CCR5 mAb (C5Mab-1; rat IgM, kappa)	specific for CCR5 (by CBIS method) ; ref: clone C34-3448 (BD); rat IgG2c; ref: clone HM-CCR5 (BioLegend); hamster (Kd: 1.6 x 10^-7) (summary)	FACS		done
anti-mouse CCR5 mAb (C5Mab-2; rat IgG2b, kappa)	specific for CCR5 by CBIS method (Kd: 4.3 x 10^-8)	FACS	C5Mab-2	done
anti-mouse CCR5 mAb (C5Mab-3; rat IgG2b, kappa)	specific for CCR5 by CBIS method (Kd: 5.8 x 10^-8)	FACS		done
anti-mouse CCR5 mAb (C5Mab-4; rat IgG2a, kappa)	specific for CCR5 by peptide immunization (Kd: 3.5 x 10^-8) immunogen: MDFQGSVPTYSYDIDYGMS	FACS, WB	C5Mab-4	done
anti-mouse CCR5 mAb (C5Mab-5; rat IgG2a, kappa)	specific for CCR5 by peptide immunization (Kd: 8.1 x 10^-8) immunogen: MDFQGSVPTYSYDIDYGMS	FACS, WB		done
anti-mouse CCR5 mAb (C5Mab-7; rat IgG1, kappa)	specific for CCR5 by peptide immunization immunogen: MDFQGSVPTYSYDIDYGMS	FACS		done
anti-mouse CCR5 mAb (C5Mab-8; rat IgG1, kappa)	specific for CCR5 by peptide immunization (Kd: 7.3 x 10^-9) immunogen: MDFQGSVPTYSYDIDYGMS	FACS, WB	C5Mab-8	done

Back to list

mouse CCR6 (CD196)	Character --> anti-human CCR6	Application	Ref	Gene cloning	Company
anti-mouse CCR6 mAb (C6Mab-9; rat IgG1, kappa)	peptide immunization immunogen: MNSTESYFGTDDYDNTEYY (summary)	FACS		done	BD
anti-mouse CCR6 mAb (C6Mab-9-mG2a-f; mIgG2a,k)	mouse IgG2a type of C6Mab-9 ref: clone 29-2L17 (BioLegend); hamster IgG ref: clone 140706 (BD); rat IgG2a	FACS		done
anti-mouse CCR6 mAb (C6Mab-10; rat IgG2a, kappa)	peptide immunization immunogen: MNSTESYFGTDDYDNTEYY	FACS, WB		done
anti-mouse CCR6 mAb (C6Mab-13; rat IgG1, kappa)	peptide immunization immunogen: MNSTESYFGTDDYDNTEYY	FACS	C6Mab-13 epitope	done

Back to list

mouse CCR7 (CD197)	Character	Application	Ref	Company
anti-mouse CCR7 mAb (C7Mab-2, rat IgG2b, kappa)	specific for mouse CCR7; ref: clone: 4B12 (Biolegend)	FACS
anti-mouse CCR7 mAb (C7Mab-4, rat IgG2a, kappa)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-5, rat IgM, kappa)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-6, rat IgM, kappa)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-7, rat IgG1, kappa)	specific for mouse CCR7	FACS, WB	in preparation (Satofuka et al)	done
anti-mouse CCR7 mAb (C7Mab-8, rat IgG2a, lambda)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-9, rat IgM, kappa)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-10, rat Ig)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-11, rat IgG1, kappa)	specific for mouse CCR7	FACS, WB(weak)
anti-mouse CCR7 mAb (C7Mab-12, rat IgG2a, lambda)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-13, rat IgM, kappa)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-14, rat IgG1, kappa)	specific for mouse CCR7	FACS
anti-mouse CCR7 mAb (C7Mab-15, rat IgG1, kappa)	specific for mouse CCR7	FACS, WB(weak)

Back to list

mouse CCR8 (CD198)	Character --> anti-human CCR8	Application	Ref	Gene cloning	Company
anti-mouse CCR8 mAb (C8Mab-1; rat IgG2a, kappa)	clone SA214G2 (BioLegend); rat IgG2b no mAb from BD patent (Shionogi/Osaka Univ.) (summary)	FACS, ICC	C8Mab-1	done
anti-mouse CCR8 mAb (C8Mab-2; rat IgG2b, kappa)	specific mouse CCR8 established by CBIS method	FACS, ICC	C8Mab-2 ICC epitope	done	Merck
anti-mouse CCR8 mAb (C8Mab-2-mG2a)	mouse IgG2a type of C8Mab-2 established by CBIS method	FACS, ICC		done
anti-mouse CCR8 mAb (C8Mab-3; rat IgG1, kappa)	specific mouse CCR8 established by CBIS method	FACS, ICC	C8Mab-3	done

Back to list

mouse CCR9 (CD199)	Character --> anti-human CCR9	Application	Ref	Gene cloning	Company
anti-mouse CCR9 mAb (C9Mab-24; rat IgG2a, kappa)	immunogen: MMPTELTSLIPGMFDDFSYC (summary) ref: clone 9B1 (BioLegend; BD); rat IgG2a ref: clone CW-1.2 (BioLegend; BD); mouse IgG2a	FACS, WB	C9Mab-24 epitope	done

Back to list

mouse CCR10	Character	Application	Ref	Gene cloning	Company
anti-mouse CCR10 mAb (CC10Mab-1; rat IgM, kappa)	CBIS method (summary) ref: clone 248918R (R&D); rat IgG2a	FACS	in preparation (Li et al)

Back to list

mouse CXCR1 (CD181)	Character	Application	Ref	Gene cloning
anti-mouse CXCR1 mAb (Cx1Mab-1; rat IgG1, kappa)	by CBIS; Kd: 2.6 x 10^-9 M (summary) ref: clone 1122A (R&D); rabbit IgG; Kd: 2.7 x 10^-9 M; clone U45-632 (BD); rat IgG2b	FACS, WB	Cx1Mab-1	done
anti-mouse CXCR1 mAb (Cx1Mab-2; rat IgG1, kappa)	Kd: 2.0 x 10^-9 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS WB (weak)
anti-mouse CXCR1 mAb (Cx1Mab-3; rat IgG2a, kappa)	Kd: 6.2 x 10^-10 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS WB (weak)
anti-mouse CXCR1 mAb (Cx1Mab-4; rat IgG1, kappa)	Kd: 2.1 x 10^-9 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS
anti-mouse CXCR1 mAb (Cx1Mab-5; rat IgG2a, kappa)	Kd: 8.2 x 10^-9 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS, WB
anti-mouse CXCR1 mAb (Cx1Mab-6; rat IgG1, kappa)	Kd: 1.0 x 10^-9 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS
anti-mouse CXCR1 mAb (Cx1Mab-7; rat Ig2b, kappa)	Kd: 8.1 x 10^-9 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS
anti-mouse CXCR1 mAb (Cx1Mab-8; rat Ig2b, kappa)	Kd: 3.0 x 10^-10 M immunogen: MAEAEYFIWTNPEGDFEKE	FACS	Cx1Mab-8

Back to list

mouse CXCR2 (CD182)	Character	Application	Ref	Gene cloning
anti-mouse CXCR2 mAb (Cx2Mab-1; rat IgG2b, kappa)	immunogen: MGEFKVDKFNIEDFFSGDL; Kd: 9.4 x 10^-9 M; ref: SA045E1 (BioLegend; Kd: 1.6 x 10^-8 M)	FACS	in preparation (Kaneko et al)	done
anti-mouse CXCR2 mAb (Cx2Mab-2; rat IgG2b, kappa)	immunogen: MGEFKVDKFNIEDFFSGDL Kd: 1.0 x 10^-8 M (summary)	FACS		done
anti-mouse CXCR2 mAb (Cx2Mab-3; rat Ig)	specific for mouse CXCR2; by CBIS method	FACS	in preparation (Kobayashi et al)
anti-mouse CXCR2 mAb (Cx2Mab-4; rat Ig)	specific for mouse CXCR2; by CBIS method	FACS

Back to list

mouse CXCR3 (CD183)	Character	Application	Ref	Gene cloning
anti-mouse CXCR3 mAb (Cx3Mab-2; rat IgG2b, kappa)	immunogen: MYLEVSERQVLDASDFAFL (summary) Kd: 5.9 x 10^-9 M; ref: clone: CXCR3-173 (BD; BioLegend); hamster IgG; Kd: 1.3 x 10^-9 M	FACS		done
anti-mouse CXCR3 mAb (Cx3Mab-4; rat IgG1, kappa)	immunogen: MYLEVSERQVLDASDFAFL Kd: 1.3 x 10^-9 M	FACS	Cx3Mab-4	done
anti-mouse CXCR3 mAb (Cx3Mab-5; rat IgG2c, kappa)	immunogen: MYLEVSERQVLDASDFAFL Kd: 5.3 x 10^-9 M	FACS		done
anti-mouse CXCR3 mAb (Cx3Mab-6; rat IgG2b, kappa)	immunogen: MYLEVSERQVLDASDFAFL Kd: 4.5 x 10^-9 M	FACS		done

Back to list

mouse CXCR4 (CD184)	Character	Application	Ref	Gene cloning
anti-mouse CXCR4 mAb (Cx4Mab-1; rat IgG2a, kappa)	by CBIS method; Kd: 6.4 x 10^-9 M; ref: clone 2B11/CXCR4 (BD), rat IgG2b; ref: clone L276F12 (BioLegend), rat IgG2b (summary)	FACS	Cx4Mab-1	done
anti-mouse CXCR4 mAb (Cx4Mab-2; rat IgG2b, kappa)	specific for mouse CXCR4 immunogen: MEPISVSIYTSDNYSEEVG; Kd: 3.0 x 10^-7 M	FACS, WB	in preparation (Yamamoto et al)
anti-mouse CXCR4 mAb (Cx4Mab-3; rat IgG2b, kappa)	specific for mouse CXCR4 immunogen: MEPISVSIYTSDNYSEEVG	FACS
anti-mouse CXCR4 mAb (Cx4Mab-4; rat IgG2b, kappa)	specific for mouse CXCR4 immunogen: MEPISVSIYTSDNYSEEVG; Kd: 5.5 x 10^-7 M	FACS, WB
anti-mouse CXCR4 mAb (Cx4Mab-5; rat IgG2b, kappa)	specific for mouse CXCR4 immunogen: MEPISVSIYTSDNYSEEVG	FACS

Back to list

mouse CXCR5 (CD185)	Character	Application	Ref
anti-mouse CXCR5 mAb (Cx5Mab-2; rat IgG2a, kappa)	immunogen: MNYPLTLDMGSITYNMDDL Kd: 7.0 x 10^-9; ref: clone 2G8 (BD) ; ref: clone L138D7 (BioLegend) (summary)	FACS
anti-mouse CXCR5 mAb (Cx5Mab-3; IgG2b, kappa)	specific for mouse CXCR5; immunogen: MNYPLTLDMGSITYNMDDL Kd: 7.2 x 10^-10	FACS	Cx5Mab-3
anti-mouse CXCR5 mAb (Cx5Mab-4; IgM, kappa)	specific for mouse CXCR5; immunogen: MNYPLTLDMGSITYNMDDL	FACS

Back to list

mouse CXCR6 (CD186)	Character	Application	Ref	Gene cloning	Company
anti-mouse CXCR6 mAb(Cx6Mab-1; rat IgG1, kappa)	specific for mouse CXCR6; immunogen: MDDGHQESALYDGHYEGDF (summary)	FACS, WB	Cx6Mab-1 epitope-1 epitope-2	done	BD
anti-mouse CXCR6 mAb(Cx6Mab-5; rat IgG1, kappa)	specific for mouse CXCR6; immunogen: MDDGHQESALYDGHYEGDF	FACS, WB		done

Back to list

mouse CX3CR1	Character	Application	Ref	Gene cloning	Company
anti-mouse CX3CR1 mAb (X3Mab-1; rat IgG1, kappa)	immunogen: MSTSFPELDLENFEYDDSA ref: clone SA011F11 (BioLgend): mouse IgG2a; ref: clone Z8-50 (BD): rat IgG2a	FACS (weak), WB (weak)
anti-mouse CX3CR1 mAb (X3Mab-2; rat IgG1, kappa)	specific for mouse CX3CR1 immunogen: MSTSFPELDLENFEYDDSA	FACS (weak), WB (weak)

Back to list

mouse ACKR1	Character	Application	Ref	Gene cloning	Company
anti-mouse ACKR1 mAb (A1Mab series)	specific for ACKR1 ref no p.c. mAbs	FACS	Ishikawa et al

Back to list

mouse ACKR2	Character	Application	Ref	Gene cloning	Company
anti-mouse ACKR2 mAb (A2Mab series)	specific for ACKR2	FACS

Back to list

mouse ACKR3 (CD187, CXCR7)	Character (summary)	Application	Ref	Gene cloning
anti-mouse ACKR3 mAb (A3Mab-1; rat IgG2a, kappa)	specific for mouse ACKR3; immunogen: MDVHLFDYAEPGNYSDINW; ref: 8F11-M1 (BioLegend; Kd: 8.3 x 10^-8 M)	FACS	in preparation (Yamamoto et al)	done
anti-mouse ACKR3 mAb (A3Mab-2; rat IgG2a, kappa)	specific for mouse ACKR3; Kd: 1.5 x 10^-8 M	FACS, WB
anti-mouse ACKR3 mAb (A3Mab-3; rat IgG2a, kappa)	specific for mouse ACKR3; Kd: 2.0 x 10^-8 M	FACS, WB
anti-mouse ACKR3 mAb (A3Mab-4; rat IgG2a, kappa	specific for mouse ACKR3	FACS
anti-mouse ACKR3 mAb (A3Mab-5; rat IgG2a, kappa)	specific for mouse ACKR3; Kd: 2.6 x 10^-9 M	FACS
anti-mouse ACKR3 mAb (A3Mab-6; rat IgG2a, kappa)	specific for mouse ACKR3; Kd: 1.9 x 10^-8 M	FACS, WB
anti-mouse ACKR3 mAb (A3Mab-7; rat IgG2a, kappa)	specific for mouse ACKR3; Kd: 1.5 x 10^-8 M	FACS, WB
anti-mouse ACKR3 mAb (A3Mab-8; rat IgG2a, kappa)	specific for mouse ACKR3; Kd: 1.9 x 10^-8 M	FACS

Back to list

mouse ACKR4 (CCR11, CCRL1)	Character	Application	Ref	Gene cloning
anti-mouse ACKR4 mAb (A4Mab-1; rat IgG2b, kappa)	immunogen: MALELNQSAEYYYEENEMN; Kd: 3.5 x 10^-9 no commercially available mAb	FACS, WB(weak)	A4Mab-1	done
anti-mouse ACKR4 mAb (A4Mab-2; rat IgG2b, kappa)	immunogen: MALELNQSAEYYYEENEMN Kd: 6.1 x 10^-9	FACS, WB	A4Mab-2	done
anti-mouse ACKR4 mAb (A4Mab-3; rat IgG2b, kappa)	immunogen: MALELNQSAEYYYEENEMN Kd: 1.6 x 10^-9	FACS	A4Mab-3	done

Back to list

mouse ACKR5	Character	Application	Ref	Gene cloning	Company
anti-mouse ACKR5 mAb (A5Mab series)	also known as CCRL2 ref: clone S21013E (BioLegend)	FACS

Back to list

mouse XCR1	Character	Application	Ref	Gene cloning	Company
anti-mXCR1 mAb	in preparation	FACS

Back to list

human CCR1	Character	Application	Ref	Gene cloning	Company
anti-hCCR1 mAb	in preparation

Back to list

human CCR2 (CD192)	Character --> anti-mouse CCR2	Application	Ref	Gene cloning	Company
anti-hCCR2 mAb (C2Mab-9; mouse IgG1, kappa)	specific for human CCR2; expressed in U937 or NK cell; peptide immunization	FACS, ICC	C2Mab-9 epitope	done

Back to list

human CCR3	Character --> anti-mouse CCR3	Application	Ref	Gene cloning	Company
anti-hCCR3 mAb (C3Mab-8; mouse IgG1, kappa)	specific for human CCR3 peptide immunization; Kd: 5.0 x 10^-9 M ref: 5E8 (BioLegend); Kd: 2.5 x 10^-9 M	FACS, WB		done

Back to list

human CCR4	Character	Application	Ref	Gene cloning	Company
anti-hCCR4 mAb	in preparation

Back to list

human CCR5	Character	Application	Ref	Gene cloning	Company
anti-hCCR5 mAb	in preparation

Back to list

human CCR6 (CD196)	Character --> anti-mouse CCR6	Application	Ref	Gene cloning	Company
anti-hCCR6 mAb (C6Mab-19; mouse IgG1, kappa)	specific for human CCR6; expressed in HepG2 or HuH-7; peptide immunization	FACS, IHC, ELISA	C6Mab-19

Back to list

human CCR7	Character	Application	Ref	Gene cloning	Company
anti-hCCR7 mAb	in preparation

Back to list

human CCR8	Character --> anti-mouse CCR8	Application	Ref	Gene cloning	Company
anti-hCCR8 mAb (C8Mab-20; mouse IgG1, kappa)	specific for human CCR8; peptide immunization; Kd: 3.2 x 10^-7 M; ref: S19017D, L263G8 (BioLegend); 433H (BD)	FACS		done
anti-hCCR8 mAb (C8Mab-21; mouse IgM, kappa)	specific for human CCR8 CBIS method Kd: 6.5 x 10^-8 M	FACS	C8Mab-21	done

Back to list

human CCR9 (CD199)	Character --> anti-mouse CCR9	Application	Ref	Gene cloning	Company
anti-hCCR9 mAb (C9Mab-1; mouse IgG1, kappa)	specific for human CCR9; developmed by CBIS method; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS	C9Mab-1; epitope ICC	done	BD; exbio
anti-hCCR9 mAb (C9Mab-6; mouse IgG1, kappa)	specific for human CCR9; established by CBIS method; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-8; mouse IgG3, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-9; mouse IgG3, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-10; mouse IgG3, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-11; mouse IgG2a, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS, WB	C9Mab-11 epitope	done
anti-hCCR9 mAb (C9Mab-12; mouse IgG1, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-13; mouse IgG2a, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-14; mouse IgG1, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-1016; mouse IgG1, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-17; mouse IgG2b, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-18; mouse IgG3, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-1019; mouse IgG1, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done
anti-hCCR9 mAb (C9Mab-21; mouse IgG3, kappa)	specific for human CCR9; established by peptide immunization; expressed in MOLT-4 (acute T lymphoblastic leukemia)	FACS		done

Back to list

human CCR10	Character	Application	Ref	Gene cloning	Company
anti-hCCR10 mAb	in preparation

Back to list

human CCR11	Character	Application	Ref	Gene cloning	Company
anti-hCCR11 mAb	in preparation

Back to list

human CXCR1	Character	Application	Ref	Gene cloning	Company
anti-hCXCR1 mAb	in preparation

Back to list

human CXCR2	Character	Application	Ref	Gene cloning	Company
anti-hCXCR2 mAb	in preparation

Back to list

human CXCR3	Character	Application	Ref	Gene cloning	Company
anti-hCXCR3 mAb	in preparation

Back to list

human CXCR4	Character	Application	Ref	Gene cloning	Company
anti-hCXCR4 mAb	in preparation

Back to list

human CXCR5	Character	Application	Ref	Gene cloning	Company
anti-hCXCR5 mAb	in preparation

Back to list

human CXCR6	Character	Application	Ref	Gene cloning	Company
anti-hCXCR6 mAb	in preparation

Back to list

human CXCR7	Character	Application	Ref	Gene cloning	Company
anti-hCXCR7 mAb	in preparation

Back to list

human XCR1	Character	Application	Gene cloning
anti-hXCR1 mAb (X1Mab-4; mouse IgG1, kappa)	specific for human XCR1; established by peptide immunization	FACS	done
anti-hXCR1 mAb (X1Mab-29; mouse IgM, kappa)	specific for human XCR1; established by peptide immunization	FACS	done
anti-hXCR1 mAb (X1Mab-47; mouse IgM, kappa)	specific for human XCR1; established by CBIS (immunization of MDA-MB-157/PA-hXCR1)	FACS

Back to list

EGFR/HER2/HER3/HER4

mouse EGFR domain-I	Character --> human EGFR	Application	Ref	Gene cloning	Company
anti-EGFR mAb; EMab-300 (rat IgG1, kappa)	specific for mouse EGFR	FACS	EMab-300	done
anti-EGFR mAb; EMab-305 (rat IgG1, lambda)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-306 (rat IgG1, lambda)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-307 (rat IgG2a, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-308 (rat IgG2a, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-309 (rat IgG2a, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb (EMab-310; rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-311 (rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-312 (rat IgM, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-313 (rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-314 (rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-315 (rat IgG2a, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-316 (rat Ig2a, lambda)	specific for mouse EGFR; crossreacts with human EGFR	FACS
anti-EGFR mAb; EMab-317 (rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-318 (rat IgG1, lambda)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-319 (rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-320 (rat IgG1, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-321 (rat IgG1, kappa)	specific for mouse EGFR	FACS, WB(weak)
anti-EGFR mAb; EMab-322 (rat IgG1, kappa)	specific for mouse EGFR	FACS, WB(weak)
anti-EGFR mAb; EMab-323 (rat IgG2a, kappa)	specific for mouse EGFR	FACS
anti-EGFR mAb; EMab-325 (rat IgG1, kappa)	specific for mouse EGFR	FACS
mouse EGFR domain-I	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb; EMab-300-scFv-Fc (mouse IgG2a)	scFv of EMab-300	FACS		ongoing
mouse EGFR domain-II	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb; EMab-301 (rat IgM, kappa)	mouse EGFR was immunized using CBIS; cross-react with human EGFR	FACS, WB		done
mouse EGFR domain-II	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb; EMab-301-rG2a (rat IgG2a, kappa)	rat IgG2a version of EMab-301; mouse EGFR was immunized using CBIS; cross-react with human EGFR	FACS, WB		done
mouse EGFR domain-III	Character	Application	Ref	Gene cloning	Company
anti-mouse/human EGFR mAb; EMab-88 (mouse IgG1, kappa)	specific for EGFR; EMab-88 was developed against human EGFR; crossreacts with mouse EGFR (domain-III)	FACS	data	done
human EGFR domain-I	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (EMab-23; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-I	FACS		done
anti-EGFR mAb (EMab-78; mouse IgG2b, kappa)	specific for EGFR; reacts with domain-I	FACS		done
anti-EGFR mAb (EMab-129; mouse IgG1, lambda)	specific for EGFR; reacts with domain-I	FACS		done
human EGFR domain-II	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (EMab-19; mouse IgG2a, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-II	FACS		done
anti-EGFR mAb (EMab-33; mouse IgG1, kappa)	specific for EGFR; reacts with domain-II	FACS		done
anti-EGFR mAb (EMab-57; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-II	FACS		done
anti-EGFR mAb (EMab-76; mouse IgG1, kappa)	specific for EGFR; reacts with domain-II	FACS		done
human EGFR domain-III	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (EMab-134; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC	EMab-134 epitope-1; -2 AirID	done	abcam BD wako
anti-EGFR mAb (134-mG2a; mouse IgG2a, kappa)	mouse IgG2a version of EMab-134; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC, ADCC/CDC, antitumor activities	134-mG2a	done
anti-EGFR mAb (EMab-51; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC	EMab-51 epitope	done
anti-EGFR mAb (51-mG2a; mouse IgG2a, kappa)	mouse IgG2a version of EMab-51specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities		done
anti-EGFR mAb (51-mG2a-f; mouse IgG2a, kappa)	core fucose-deficient mouse IgG2a version of EMab-51; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities		done
anti-EGFR mAb (EMab-17; mouse IgG2a, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, ADCC/CDC, antitumor activities	EMab-17 metastasis	done
anti-EGFR mAb (recEMab-17-f; mouse IgG2a)	core fucose-deficient mouse IgG2a version of EMab-17; specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, ADCC/CDC, antitumor activities		done
anti-EGFR mAb (EMab-1; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		done
anti-EGFR mAb (EMab-32; mouse IgG2a, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		done
anti-EGFR mAb (EMab-114; mouse IgG2b, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		done
anti-EGFR mAb (EMab-125; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB		done
anti-EGFR mAb (EMab-139; mouse IgG1, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS, WB		done
anti-EGFR mAb (EMab-151; mouse IgG2b, kappa)	specific for EGFR; crossreacts with dog EGFR; reacts with domain-III	FACS		done
anti-EGFR mAb (cetuximab; human IgG1,kappa)	specific for EGFR (Erbitax)	FACS		done
anti-EGFR mAb (panitumumab; human IgG2,kappa)	specific for EGFR (Vectibix; epitope)	FACS		done
human EGFR domain-IV	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (EMab-95; mouse IgG1, kappa)	specific for EGFR; reacts with domain-IV	FACS		done
anti-EGFR mAb (EMab-110; mouse IgG1, kappa)	specific for EGFR; reacts with domain-IV	FACS		done
dog EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (134-mG2a-f; mouse IgG2a)	core fucose-deficient mouse IgG2a version of EMab-134; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities	CHO/dEGFR OS; Fibro Mammary	done
anti-EGFR mAb (E134Bf; canine IgGB, kappa)	core fucose-deficient canine IgGB version of EMab-134; specific for EGFR	FACS, WB, IHC, ADCC, CDC, antitumor activities	Mammary Fibro & Osteo	done
bispecific	Character	Application	Ref	Gene cloning	Company
anti-dog EGFR-dog HER2 mAb (E134B-H77scFv-f)	bispecific mAb for EGFR and HER2	FACS, WB, IHC, ADCC, CDC, antitumor activities	E134B-H77scFv-f	done
anti-EGFR-PDPN mAb (E134-NZ1scFv-mG2a-f)	bispecific mAb for EGFR and PDPN	FACS, WB, IHC, ADCC, CDC, antitumor activities		done

Back to list

mouse HER2 (CD340)	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-300 ; rat IgG2b, kappa)	specific for mouse HER2 (domain-I) does not cross-react with dog HER2	FACS	H2Mab-300	done
anti-HER2 mAb (H2Mab-303 ; rat IgG2a, kappa)	specific for mouse HER2 (domain-I) does not cross-react with dog HER2	FACS		done
anti-HER2 mAb (H2Mab-304 ; rat IgG1, kappa)	specific for mouse HER2 (domain-I) does not cross-react with dog HER2	FACS, WB	H2Mab-304	done
anti-HER2 mAb (H2Mab-307 ; rat IgG2a, kappa)	specific for mouse HER2 (domain-I) does not cross-react with dog HER2	FACS		done
anti-HER2 mAb (H2Mab-314 ; rat IgG1, kappa)	specific for mouse HER2 (domain-I) does not cross-react with dog HER2	FACS, WB		done
HER2 domain-I	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-77; mouse IgG1, kappa)	specific for HER2; crossreacts with dog HER2; (ref: TNBC)	FACS, WB, IHC	H2Mab-77	done	BioLegnd
anti-HER2 mAb (H2Mab-77-mG2a-f; mouse IgG2a)	specific for HER2; crossreacts with dog HER2; (ref: TNBC)	FACS, WB, IHC	77-mG2a-f	done
anti-HER2 mAb (H2Mab-77-hG1; human IgG1)	specific for HER2; crossreacts with dog HER2; (ref: TNBC)	FACS, WB, IHC		done
anti-HER2 mAb (H77Bf; canine IgGB, kappa)	core fucose-deficient canine IgGB version of H2Mab-77	FACS, WB, IHC, ADCC/CDC, antitumor activities	H77Bf OS fibro	done
anti-HER2 mAb (H2Mab-119; mouse IgG1, kappa)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	H2Mab-119 structure H2Mab-250	done
anti-HER2 mAb (H2Mab-119-mG2a-f; mouse IgG2a)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	119-mG2a-f	done
anti-HER2 mAb (H2Mab-119-hG1; human IgG1)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC		done
anti-HER2 mAb (H2Mab-139; mouse IgG1, kappa)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	H2Mab-139	done	abcam
anti-HER2 mAb (H2Mab-139-mG2a;mouse IgG2a)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC		done
anti-HER2 mAb (H2Mab-139-mG2a-f; mouse IgG2a)	specific for HER2; crossreacts with dog HER2	FACS, WB, IHC	139-mG2a-f	done
anti-HER2 mAb (H2Mab-1245; mouse IgG1,kappa)	Mab-34; specific for human HER2 does not cross-react with endogenous dog HER2	FACS		done
anti-HER2 mAb (H2Mab-1268; mouse IgG1,kappa)	Mab-35; specific for HER2 or endogenous dog HER2	FACS		done
anti-HER2 mAb (H2Mab-1278; mouse IgG1,kappa)	Mab-38; specific for HER2 or endogenous dog HER2	FACS		done
HER2 domain-II	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-32; mouse IgG1, kappa)	specific for HER2	FACS		done
anti-HER2 mAb (H2Mab-133; mouse IgG1, kappa)	specific for HER2	FACS		done
anti-HER2 mAb (H2Mab-193; mouse IgG1, kappa)	specific for HER2	FACS	H2Mab-250	done
anti-HER2 mAb (H2Mab-215; mouse IgG1, kappa)	specific for HER2	FACS	H2Mab-250	done
(anti-HER2 mAb (pertuzumab; human IgG1,kappa)	specific for HER2 (Perjeta)	FACS		done
HER2 domain-III	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-19; mouse IgG2b, kappa)	specific for HER2; crossreacts with mouse HER2 (CHO/mHER2) or dog HER2; not react with NMuMG (mouse breast cancer)	FACS, ADCC/CDC, antitumor activities	PC; CRC; GBM	done
anti-HER2 mAb (H2Mab-181; mouse IgG1, kappa)	specific for HER2; crossreacts with dog HER2; domain-III; epitope: p373-392	FACS, WB, IHC	H2Mab-181 epitope	done
anti-HER2 mAb (H2Mab-1180; mouse IgG1, kappa)	Mab-33; specific for human HER2 does not cross-react with endogenous dog HER2	FACS		done
anti-HER2 mAb (H2Mab-1190; mouse IgG1,kappa)	Mab-36; specific for HER2 does not cross-react with endogenous dog HER2	FACS		done
anti-HER2 mAb (H2Mab-1262; mouse IgG1,kappa)	Mab-37; specific for HER2 does not cross-react with endogenous dog HER2	FACS		done
HER2 domain-IV	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-41; mouse IgG2b, kappa)	specific for HER2; crossreacts with dog HER2; domain-IV	FACS, antitumor activities	H2Mab-41 dogHER2	done
(anti-HER2 mAb (trastuzumab; human IgG1,kappa)	specific for HER2	FACS	H2Mab-250 H2Mab-214	done
anti-HER2 mAb (trastuzumab-f; human IgG1,kappa)	defucosylated trastuzumab; specific for HER2	FACS	250_in vivo	done
anti-HER2 mAb (tras-mG2a-f; mouse IgG2a,kappa)	specific for HER2 mouse IgG2a-version of trastuzumab defucosylated	FACS	250_in vivo	done

Back to list

HER3	Character	Application	Ref	Gene cloning	Company
anti HER3 mAb (H3Mab-17; mouse IgG2a, kappa)	specific for HER3	FACS, ADCC/CDC, antitumor activities	H3Mab-17	done	exbio
anti-HER3 mAb (patritumab; human IgG2,kappa)	specific for HER3 (Patritumab)	FACS		done

Back to list

HER4	Character	Application	Ref	Gene cloning	Company
anti-HER4 mAb (H4Mab-12; mouse IgG2a, kappa)	Kd: 3.1 x 10^-10 M for T-47D ref: clone P6-1 (BD; CosmoBio: rat IgG2a; Kd: 2.8 x 10^-10 M for T-47D)	FACS		done
anti-HER4 mAb (H4Mab-16; mouse IgG1, kappa)	immunization of LN229/HER4 Kd: 1.2 x 10^-9 M for T-47D	FACS		done

Back to list

Immune checkpoint

KLRG1	Character	Application	Ref	Gene cloning	Company
anti-KLRG1 mAb (KLMab-1; mouse IgG1, kappa)	specific for human KLRG1	FACS, ICC	KLMab-1 ICC	done

Back to list

PD-L1 (CD274/B7H1)	Character	Application	Ref	Gene cloning	Company
anti-PD-L1 mAb (L1Mab-13; mouse IgG1, kappa)	specific for human PD-L1	FACS, WB, IHC (cell), IHC (tissue), ELISA	L1Mab-13	done
anti-PD-L1 mAb (13-mG2a-f; mouse IgG2a, kappa)	specific for human PD-L1; core fucose-deficient IgG2a of L1Mab-13	FACS, WB, IHC (cell), IHC (tissue), ELISA, ADCC/CDC, antitumor activities	13-mG2a-f	done
dog PD-L1	Character	Application	Ref	Gene cloning	Company
anti-dog PD-L1 mAb (L1Mab-347; mouse IgG1, kappa)	specific for dog PD-L1 (extracellular domain)	FACS, IHC		done
anti-dog PD-L1 mAb (L1Mab-352; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-352	done
anti-dog PD-L1 mAb (L1Mab-354; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-354	done

Back to list

PD-L2 (CD273/B7H2)	Character	Application	Ref	Gene cloning	Company
anti-PD-L2 mAb (L2Mab-1; mouse IgG2b, kappa)	specific for human PD-L2	FACS, WB, IHC (cell)		done

Back to list

TIGIT	Character	Application	Ref	Gene cloning	Company
anti-TIGIT mAb (TgMab-1; mouse IgG1, kappa)	specific for human TIGIT	FACS KD: 6.7 x 10^-10		done
anti-TIGIT mAb (TgMab-2; mouse IgG1, kappa)	specific for human TIGIT	FACS, WB, ICC KD: 3.5 x 10^-9	TgMab-2 ICC	done	BD

Back to list

Monoclonal antibodies for the other membrane proteins

CA4	Character	Application	Ref	Gene cloning	Company
anti-CA4 mAb (CA4Mab-1; rat IgG1, kappa)	specific for mouse carbonic anhydrase IV (CA4)	FACS, ELISA		done
anti-CA4 mAb (CA4Mab-2; rat IgG1, kappa)	specific for mouse carbonic anhydrase IV (CA4)	FACS, ELISA		done

Back to list

CD10	Character	Application	Ref	Gene cloning	Company
anti-CD10 mAb (C10Mab-31; mouse IgG1, kappa)	specific for CD10; CBIS method	FACS	C10Mab-31 RCC	done

Back to list

CD19	Character	Application	Ref	Gene cloning	Company
anti-CD19 mAb (C19Mab-1; mouse IgG1, kappa)	specific for CD19; CBIS method; LN229/CD19 immunization	FACS	C19Mab-1	done
anti-CD19 mAb (C19Mab-3; mouse IgG1, kappa)	specific for CD19; CBIS method; ectodomain of CD19 immunization	IHC,WB	C19Mab-3	done

Back to list

CD20	Character	Application	Ref	Gene cloning	Company
anti-CD20 mAb (C20Mab-11; mouse IgM, kappa)	specific for CD20	FACS, WB, IHC	C20Mab-11 epitope	ongoing
anti-CD20 mAb (C20Mab-60; mouse IgG2a, kappa)	specific for CD20; ref: rituximab	FACS, WB, IHC	C20Mab-60 epitope-1 epitope-2	done	BioLegnd
CD20	Character	Application	Ref	Gene cloning	Company
anti-CD20 mAb (rituximab; human IgG1, kappa)	specific for human CD20 (Rituxan)	FACS		done
anti-CD20 mAb (obinutuzumab; human IgG1, kappa)	specific for human CD20 (GAZYVA)	FACS		done
anti-CD20 mAb (ofatumumab; human IgG1, kappa)	specific for human CD20 (Kesimpta)	FACS		done

Back to list

CD39	Character	Application	Ref	Gene cloning	Company
anti-CD39 mAb (C39Mab-1; rat IgG2a, kappa)	specific for mouse CD39	FACS, WB	C39Mab-1 epitope	done
anti-CD39 mAb (C39Mab-2; rat IgG2a, lambda)	specific for mouse CD39	FACS	C39Mab-2	done
CD39	Character	Application	Ref	Gene cloning	Company
anti-CD39 mAb (C39Mab-1-ratM; rat IgM, kappa)	specific for mouse CD39	FACS, WB		done

Back to list

CD44s	Character	Application	Ref	Gene cloning	Company
anti-CD44s mAb (C44Mab-5; mouse IgG1, kappa)	Specific for CD44s (CD44 standard)	IHC, FACS, WB	C44Mab-5 epitope 5-mG2a-f	done	abcam BioLegnd
anti-CD44s mAb (C44Mab-46; mouse IgG1, kappa)	specific for CD44s (CD44 standard)	FACS, IHC, WB	C44Mab-46 epitope1 epitope2 C44Mab-46-mG2a	done
CD44v3	Character	Application	Ref	Gene cloning	Company
anti-CD44v3 mAb (C44Mab-6; mouse IgG1, kappa)	specific for CD44v3 (oral cancer and colon cancer)	FACS, WB, IHC, ELISA	C44Mab-6(IJMS) FACS(CAS)	done
CD44v4	Character	Application	Ref	Gene cloning	Company
anti-CD44v4 mAb (C44Mab-108; mouse IgG1, kappa)	specific for CD44v4 (oral cancer)	WB, IHC, ELISA	C44Mab-108(CIMB) epitope(MAB)	done	Merck
CD44v5	Character	Application	Ref	Gene cloning	Company
anti-CD44v5 mAb (C44Mab-3; mouse IgG1, kappa)	specific for CD44v5 (pancreatic cancer)	FACS, WB, IHC, ELISA	C44Mab-3 (antibodies)	done	Merck
CD44v6	Character	Application	Ref	Gene cloning	Company
anti-CD44v6 mAb (C44Mab-9; mouse IgG1, kappa)	specific for CD44v6 (colon cancer)	FACS, WB, IHC, ELISA	C44Mab-9 (IJMS)	done	Merck
CD44v7	Character	Application	Ref	Gene cloning	Company
anti-CD44v7/v8 mAb (C44Mab-34; mouse IgG1, kappa)	specific for CD44v7/v8 (oral cancer)	FACS, WB, IHC, ELISA	C44Mab-34 (Biomedicines)	done
CD44v8	Character	Application	Ref	Gene cloning	Company
anti-CD44v8 mAb (C44Mab-94; mouse IgG1, kappa)	specific for CD44v8 (gastric cancer)	FACS, WB, IHC, ELISA	C44Mab-94 (antibodies)	done
CD44v9	Character	Application	Ref	Gene cloning	Company
anti-CD44v9 mAb (C44Mab-1; mouse IgG1, kappa)	specific for CD44v9 (colon cancer)	FACS, WB, IHC, ELISA	C44Mab-1(CIMB) FACS(CAS)	done
CD44v10	Character	Application	Ref	Gene cloning	Company
anti-CD44v10 mAb (C44Mab-18; mouse IgM, kappa)	specific for CD44v10 (oral cancer)	FACS, WB, IHC, ELISA	C44Mab-18(CIMB) C44Mab-18-mG2a	done
CD44s	Character	Application	Ref	Gene cloning	Company
anti-CD44s mAb (5-mG2a-f; mouse IgG2a)	mouse IgG2a version of C44Mab-5; specific for CD44s (CD44 standard)	IHC, FACS, ADCC, CDC, antitumor activities	5-mG2a-f	done
anti-CD44s mAb (C44Mab-46-mG2a-f; mouse IgG2a)	mouse IgG2a version of C44Mab-46 specific for CD44s (CD44 standard)	IHC, FACS, WB	C44Mab-46-mG2a	done
CD44v3	Character	Application	Ref	Gene cloning	Company
anti-CD44v3 mAb (C44Mab-6-mG2a-f; mouse IgG2a)	IgG2a version of C44Mab-6	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v4	Character	Application	Ref	Gene cloning	Company
anti-CD44v4 mAb (C44Mab-112; mouse IgG1, kappa)	specific for CD44v4 crossreact with mouse CD44	WB, IHC, ELISA		done
anti-CD44v4 mAb (C44Mab-118; mouse IgG1, kappa)	specific for CD44v4 crossreact with mouse CD44	WB, IHC, ELISA		done
CD44v5	Character	Application	Ref	Gene cloning	Company
anti-CD44v5 mAb (C44Mab-3-mG2a-f; mouse IgG2a)	IgG2a version of C44Mab-3	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v6	Character	Application	Ref	Gene cloning	Company
anti-CD44v6 mAb (C44Mab-9-mG2a-f; mouse IgG2a)	IgG2a version of C44Mab-9	FACS, WB, IHC, ELISA	ongoing	ongoing
anti-CD44v6 mAb (bivatuzumab; human IgG1, kappa)	specific for CD44v6	ref		done
anti-CD44v6 mAb (biva-mG1; mouse IgG2a, kappa)	specific for CD44v6 mouse IgG1 type
CD44v7	Character	Application	Ref	Gene cloning	Company
anti-CD44v7/v8 mAb (C44Mab-34-mG2a-f; mouse IgG2a)	mouse IgG2a version of C44Mab-34	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v8	Character	Application	Ref	Gene cloning	Company
anti-CD44v8 mAb (C44Mab-94-mG2a-f; mouse IgG2a)	mouse IgG2a version of C44Mab-94	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v9	Character	Application	Ref	Gene cloning	Company
anti-CD44v9 mAb (C44Mab-1-mG2a-f; mouse IgG2a)	mouse IgG2a version of C44Mab-1	FACS, WB, IHC, ELISA	ongoing	ongoing
CD44v10	Character	Application	Ref	Gene cloning	Company
anti-CD44v10 mAb (C44Mab-18-mG1; mouse IgG1, kappa)	mouse IgG1 version of CD44v10	FACS, WB, IHC, ELISA		done
anti-CD44v10 mAb (C44Mab-18-mG2a-f; mouse IgG2a)	mouse IgG2a version of C44Mab-18	FACS, WB, IHC, ELISA	C44Mab-18-mG2a	done

Back to list

CD73	Character	Application	Ref
anti-CD73 mAb (C73Mab-1; rat IgG2a, lambda)	specific for mouse CD73	FACS	in preparation (Kaneko et al)
anti-CD73 mAb (C73Mab-2; rat IgG2a, lambda)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-3; rat IgM)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-4; rat IgG2a, lambda)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-5; rat Ig)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-6; rat IgG2a, kappa)	specific for mouse CD73	FACS, WB
anti-CD73 mAb (C73Mab-7; rat Ig)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-8; rat IgG2a, lambda)	specific for mouse CD73	FACS, WB
anti-CD73 mAb (C73Mab-9; rat IgG2a, lambda)	specific for mouse CD73	FACS, WB
anti-CD73 mAb (C73Mab-10; rat IgG2a, lambda)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-11; rat Ig)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-12; rat Ig)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-13; rat IgG2b, lambda)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-14; rat Ig)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-15; rat IgG2a, lambda)	specific for mouse CD73	FACS
anti-CD73 mAb (C73Mab-16; rat IgG2a, lambda)	specific for mouse CD73	FACS, WB
anti-CD73 mAb (C73Mab-17; rat IgG2a, lambda)	specific for mouse CD73	FACS

Back to list

CD133	Character	Application	Ref	Gene cloning	Company
anti-CD133 mAb (CMab-43; mouse IgG2a, kappa)	specific for CD133	FACS, WB, IHC, ADCC/CDC, antitumor activities	CMab-43 in vivo	done	abcam BD
anti-CD133 mAb (CMab-44; mouse IgG1, kappa)	specific for CD133; detects AML	FACS, WB		done

Back to list

CD271 (NGFR)	Character	Application	Ref	Gene cloning	Company
anti-CD271 mAb (G4B1; mouse IgG2a, kappa)	cancer-specific mAb for CD271	FACS, WB, IHC	anti-CD271 mAb	done	Merck

Back to list

CD273 (PD-L2/B7H2)	Character	Application	Ref	Gene cloning	Company
anti-PD-L2 mAb	--> PD-L2

Back to list

CD274 (PD-L1/B7H1)	Character	Application	Ref	Gene cloning	Company
anti-PD-L1 mAb	--> PD-L1

Back to list

CD276 (B7H3)	Character	Application
anti-CD276 mAb (C276Mab-1; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-2; mouse IgG2b, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-3; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-4; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-5; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-6; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-7; mouse IgG3, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-8; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-9; mouse IgM, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-10; mouse IgM, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-11; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-12; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-13; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-14; mouse IgG2b, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-15; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-16; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-17; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-18; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-19; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-20; mouse IgG2a, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-21; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-22; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-23; mouse IgG2b, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-24; mouse IgG2b, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-25; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-26; mouse IgG1, kappa)	specific for CD276	FACS, WB
anti-CD276 mAb (C276Mab-27; mouse IgG1, kappa)	specific for CD276
anti-CD276 mAb (C276Mab-28; mouse IgG1, kappa)	specific for CD276

Back to list

CDH1	Character	Application	Ref	Gene cloning	Company
anti-CDH1 mAb Ca1Mab series	specific for CDH1

Back to list

CDH2	Character	Application	Ref	Gene cloning	Company
anti-CDH2 mAb Ca2Mab series	specific for CDH2

Back to list

CDH3	Character	Application
anti-CDH3 mAb Ca3Mab-5 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-6 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-7 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-8 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-12 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-16 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-17 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-18 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-19 (mouse IgG1, kappa)	specific for CDH3	FACS, WB
anti-CDH3 mAb Ca3Mab-20 (mouse IgG1, kappa)	specific for CDH3	FACS, WB

Back to list

CDH4	Character	Application	Ref	Gene cloning	Company
anti-CDH4 mAb Ca4Mab series	specific for CDH4

Back to list

CDH5	Character	Application	Ref	Gene cloning	Company
anti-CDH5 mAb Ca5Mab series	specific for CDH5

Back to list

CDH6	Character	Application	Ref	Gene cloning	Company
anti-CDH6 mAb Ca6Mab series	specific for CDH6

Back to list

CDH7	Character	Application	Ref	Gene cloning	Company
anti-CDH7 mAb Ca7Mab series	specific for CDH7

Back to list

CDH8	Character	Application	Ref
anti-CDH8 mAb (Ca8Mab-1, mouse IgG1, kappa)	specific for CDH8 Kd: 1.3x10^-8 M	FACS, WB(weak), IHC
anti-CDH8 mAb (Ca8Mab-2, mouse IgG1, kappa)	specific for CDH8 Kd: 1.4x10^-7 M	FACS, WB(weak)
anti-CDH8 mAb (Ca8Mab-3, mouse IgG1, kappa)	specific for CDH8	FACS
anti-CDH8 mAb (Ca8Mab-4, mouse IgG1, kappa)	specific for CDH8 Kd: 3.8x10^-9 M	FACS, WB, IHC	in preparation

Back to list

CDH9	Character	Application	Ref	Gene cloning	Company
anti-CDH9 mAb Ca9Mab series	specific for CDH9

Back to list

CDH10	Character	Application	Ref	Gene cloning	Company
anti-CDH10 mAb Ca10Mab series	specific for CDH10

Back to list

CDH11	Character	Application	Ref	Gene cloning	Company
anti-CDH11 mAb Ca11Mab series	specific for CDH11

Back to list

CDH12	Character	Application	Ref	Gene cloning	Company
anti-CDH12 mAb Ca12Mab series	specific for CDH12

Back to list

CDH13	Character	Application	Ref	Gene cloning	Company
anti-CDH13 mAb Ca13Mab series (mouse Ig)	specific for CDH13 no p.c. mAbs	FACS	Kobayashi et al

Back to list

CDH15	Character	Application
anti-CDH15 mAb Ca15Mab-1 (mouse Ig)	specific for CDH15	FACS (Saos-2, C2C12), WB
anti-CDH15 mAb Ca15Mab-2 (mouse Ig)	specific for CDH15	FACS, WB
anti-CDH15 mAb Ca15Mab-3 (mouse Ig)	specific for CDH15	FACS, WB
anti-CDH15 mAb Ca15Mab-4 (mouse Ig)	specific for CDH15	FACS, WB
anti-CDH15 mAb Ca15Mab-5 (mouse Ig)	specific for CDH15	FACS, WB
anti-CDH15 mAb Ca15Mab-6 (mouse Ig)	specific for CDH15	FACS, WB
anti-CDH15 mAb Ca15Mab-7 (mouse Ig)	specific for CDH15	FACS

Back to list

CDH16	Character	Application	Ref	Gene cloning	Company
anti-CDH16 mAb Ca16Mab series	specific for CDH16

Back to list

CDH17	Character	Application	Ref	Gene cloning	Company
anti-CDH17 mAb Ca17Mab series	specific for CDH17

Back to list

CDH18	Character	Application	Ref	Gene cloning	Company
anti-CDH18 mAb Ca18Mab series	specific for CDH18

Back to list

CDH19	Character	Application	Ref	Gene cloning	Company
anti-CDH19 mAb Ca19Mab series	specific for CDH19

Back to list

CDH20	Character	Application	Ref	Gene cloning	Company
anti-CDH20 mAb Ca20Mab series	specific for CDH20

Back to list

CDH21	Character	Application	Ref	Gene cloning	Company
anti-CDH21 mAb Ca21Mab series	specific for CDH21

Back to list

CDH22	Character	Application	Ref	Gene cloning	Company
anti-CDH22 mAb Ca22Mab series	specific for CDH22

Back to list

CDH23	Character	Application	Ref	Gene cloning	Company
anti-CDH23 mAb Ca23Mab series	specific for CDH23

Back to list

CDH24	Character	Application	Ref	Gene cloning	Company
anti-CDH24 mAb Ca24Mab series	specific for CDH24

Back to list

CDH25	Character	Application	Ref	Gene cloning	Company
anti-CDH25 mAb Ca25Mab series	specific for CDH25

Back to list

mouse EpCAM (CD326)	Character	Application	Ref	Gene cloning	Company
anti-EpCAM mAb (EpMab-160; rat IgG2b, kappa)	specific for mouse EpCAM	FACS	in preparation (Li G et al)
anti-EpCAM mAb (EpMab-161; rat IgG2b, kappa)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-162; rat IgG2a, kappa)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-163; rat IgG2c, kappa)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-164; rat IgM, kappa)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-165; rat IgG2a, kappa)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-166; rat IgM, kappa)	specific for mouse EpCAM crossreact with human EpCAM (only exogenous)	FACS
anti-EpCAM mAb (EpMab-167; rat IgM, kappa)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-168; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-169; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-170; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-171; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-172; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-173; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-174; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-175; rat Ig)	specific for mouse EpCAM crossreact with human EpCAM (only exogenous)	FACS
anti-EpCAM mAb (EpMab-176; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-177; rat Ig)	specific for mouse EpCAM	FACS
anti-EpCAM mAb (EpMab-178; rat Ig)	specific for mouse EpCAM	FACS
human EpCAM (CD326)	Character	Application	Ref	Gene cloning	Company
anti-EpCAM mAb (EpMab-16; mouse IgG2a, kappa)	specific for EpCAM	FACS, WB, IHC	EpMab-16 (1) EpMab-16 (2)	done	merck
anti-EpCAM mAb (EpMab-37; mouse IgG1, kappa)	specific for EpCAM	FACS, WB, IHC	EpMab-37 epitope	done
anti-EpCAM mAb (EpMab-37-mG2a-f; mouse IgG2a)	specific for EpCAM	FACS, WB, IHC, ADCC, CDC, antitumor activities	EpMab-37 (1) EpMab-37 (2)	done
anti-EpCAM mAb (EpMab-3; mouse IgG1, kappa)	specific for EpCAM	FACS		done

Back to list

EphA1	Character	Application
anti-EphA1 mAb Ea1Mab-5 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-7 (mouse IgG2a, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-14 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-15 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-20 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-28 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-30 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-35 (mouse IgG1, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-43 (mouse IgG2a, kappa)	specific for EphA1	FACS, WB
anti-EphA1 mAb Ea1Mab-46 (mouse IgG1, kappa)	specific for EphA1	FACS, WB

Back to list

EphA2	Character	Application	Ref	Gene cloning	Company
anti-EphA2 mAb Ea2Mab-1 (mouse IgG1, kappa)	specific for EphA2 ref: clone SHM16 (BioLegend; Kd: 8.4 x 10^-9 for CHO/hEphA2)	FACS
anti-EphA2 mAb Ea2Mab-2 (mouse IgG2a, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-3 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-4 (mouse IgG2b, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-5 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-6 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-7 (mouse IgG1, kappa)	specific for EphA2 Kd: 7.7 x 10^-9 for CHO/hEphA2	FACS, WB, IHC	Ea2Mab-7	done
anti-EphA2 mAb Ea2Mab-8 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-9 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-10 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-11 (mouse IgG1, kappa)	specific for EphA2	FACS
anti-EphA2 mAb Ea2Mab-12 (mouse IgG1, kappa)	specific for EphA2	FACS
EphA2	Character	Application	Ref	Gene cloning	Company
anti-EphA2 mAb Ea2Mab-7-mG2a (mouse IgG2a, kappa)	mouse IgG2a version of Ea2Mab-7	FACS, WB, IHC
anti-EphA2 mAb Ea2Mab-7-hG1 (human IgG1, kappa)	human IgG1 version of Ea2Mab-7	FACS, WB, IHC

Back to list

EphA3	Character	Application	Ref
anti-EphA3 mAb Ea3Mab-1 (mouse IgG1, kappa)	specific for EphA3; Kd: 4.8 x 10^-10; ref: clone: IIIA4 (absolute antibody; Kd: 6.3 x 10^-10)	FACS	in preparation (Hirose et al)
anti-EphA3 mAb Ea3Mab-2 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-3 (mouse IgG1, kappa)	specific for EphA3; Kd: 8.8 x 10^-9	FACS
anti-EphA3 mAb Ea3Mab-4 (mouse IgG1, kappa)	specific for EphA3; Kd: 2.3 x 10^-9	FACS
anti-EphA3 mAb Ea3Mab-5 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-6 (mouse IgM, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-7 (mouse IgG1, kappa)	specific for EphA3; Kd: 6.7 x 10^-9	FACS
anti-EphA3 mAb Ea3Mab-8 (mouse IgG1, kappa)	specific for EphA3; Kd: 4.6 x 10^-9	FACS
anti-EphA3 mAb Ea3Mab-9 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-10 (mouse IgG1, kappa)	specific for EphA3; Kd: 2.5 x 10^-9	FACS
anti-EphA3 mAb Ea3Mab-11 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-12 (mouse IgG1, kappa)	specific for EphA3; Kd: 4.6 x 10^-9	FACS
anti-EphA3 mAb Ea3Mab-13 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-14 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-15 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-16 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-17 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-18 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-19 (mouse IgG1, kappa)	specific for EphA3	FACS
anti-EphA3 mAb Ea3Mab-20 (mouse IgG1, kappa)	specific for EphA3	FACS

Back to list

EphA4	Character	Application	Ref
anti-EphA4 mAb Ea4Mab-1 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-2 (mouse IgG1, kappa)	specific for EphA4	FACS, IHC
anti-EphA4 mAb Ea4Mab-3 (mouse IgG1, kappa)	specific for EphA4	FACS, WB, IHC	in preparation (Li et al)
anti-EphA4 mAb Ea4Mab-4 (mouse IgG2b, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-5 (mouse IgG1, kappa)	specific for EphA4	FACS, IHC
anti-EphA4 mAb Ea4Mab-6 (mouse IgG1, kappa)	specific for EphA4	FACS, IHC
anti-EphA4 mAb Ea4Mab-7 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-8 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-9 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-10 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-11 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-12 (mouse IgG1, kappa)	specific for EphA4	FACS
anti-EphA4 mAb Ea4Mab-13 (mouse IgG1, kappa)	specific for EphA4	FACS

Back to list

EphA5	Character	Application	Ref
anti-EphA5 mAb Ea5Mab-1 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS, IHC
anti-EphA5 mAb Ea5Mab-2 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-3 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS, IHC
anti-EphA5 mAb Ea5Mab-4 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-5 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS, WB, IHC	in preparation (Li et al)
anti-EphA5 mAb Ea5Mab-6 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-7 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS, WB, IHC	in preparation (Li et al)
anti-EphA5 mAb Ea5Mab-8 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-9 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-10 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-11 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-12 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS
anti-EphA5 mAb Ea5Mab-13 (mouse IgG1, kappa)	specific for human EphA5 established by CBIS method	FACS

Back to list

EphA6	Character	Application	Ref
anti-EphA6 mAb (Ea6Mab-1, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method no ref mAb	FACS	in preparation (Li G et al)
anti-EphA6 mAb (Ea6Mab-2, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-3, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-4, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-5, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-6, mouse IgM, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-7, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-8, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-9, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-10, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-11, mouse IgG1, kappa)	specific for human EphA6 established by CBIS method	FACS
anti-EphA6 mAb (Ea6Mab-12, mouse Ig)	specific for human EphA6 established by CBIS method	FACS

Back to list

EphA7	Character	Application	Ref
anti-EphA7 mAb Ea7Mab-1 (mouse IgM, kappa)	specific for human EphA7	FACS
anti-EphA7 mAb Ea7Mab-2 (mouse IgG1, kappa)	specific for human EphA7 Kd: 2.0 x 10^-9 M for CHO/EphA7 9.2 x 10^-9 M for LN229/EphA7	FACS, WB
anti-EphA7 mAb Ea7Mab-3 (mouse IgG1, kappa)	specific for human EphA7	FACS
anti-EphA7 mAb Ea7Mab-4 (mouse IgG1, kappa)	specific for human EphA7 Kd: 1.7 x 10^-8 M for CHO/EphA7 2.7 x 10^-8 M for LN229/EphA7	FACS, WB
anti-EphA7 mAb Ea7Mab-5 (mouse IgG1, kappa)	specific for human EphA7	FACS, WB
anti-EphA7 mAb Ea7Mab-6 (mouse IgG1, kappa)	specific for human EphA7	FACS
anti-EphA7 mAb Ea7Mab-7 (mouse IgG1, kappa)	specific for human EphA7	FACS
anti-EphA7 mAb Ea7Mab-8 (mouse IgG1, kappa)	specific for human EphA7 Kd: 8.7 x 10^-9 M for CHO/EphA7 4.7 x 10^-8 M for LN229/EphA7	FACS, WB
anti-EphA7 mAb Ea7Mab-9 (mouse IgG1, kappa)	specific for human EphA7 Kd: 6.5 x 10^-7 M for CHO/EphA7 6.7 x 10^-5 M for LN229/EphA7	FACS, WB
anti-EphA7 mAb Ea7Mab-10 (mouse IgG1, kappa)	specific for human EphA7 Kd: 1.3 x 10^-7 M for CHO/EphA7 6.5 x 10^-8 M for LN229/EphA7	FACS, WB, IHC	in preparation
anti-EphA7 mAb Ea7Mab-11 (mouse IgM, kappa)	specific for human EphA7	FACS
anti-EphA7 mAb Ea7Mab-12 (mouse IgM, kappa)	specific for human EphA7	FACS
anti-EphA7 mAb Ea7Mab-13 (mouse IgG1, kappa)	specific for human EphA7	FACS, WB

Back to list

EphA8	Character	Application	Ref
anti-EphA8 mAb (Ea8Mab-1, mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 1.9 x 10^-9 for CHO/EphA8; no ref mAb	FACS	in preparation (Yamamoto et al)
anti-EphA8 mAb (Ea8Mab-2, mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 2.3 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-3, mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 3.4 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-4, mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 8.7 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-5, mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 2.2 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-6,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 5.5 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-7,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-8,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 4.1 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-9,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 1.3 x 10^-9 for CHO/EphA8	FACS
anti-EphA8 mAb (Ea8Mab-10,mouse IgG1, lambda)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-11,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method; Kd: 2.0 x 10^-9	FACS
anti-EphA8 mAb (Ea8Mab-12,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-13,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-14,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-15,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-16,mouse IgG3, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-17,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS
anti-EphA8 mAb (Ea8Mab-18,mouse IgG1, kappa)	specific for human EphA8 established by CBIS method	FACS

Back to list

EphA10	Character	Application	Ref
anti-EphA10 mAb Ea10Mab-1 (mouse IgG1, kappa)	specific for human EphA10 established by CBIS method	FACS	in preparation (Ubukata et al)
anti-EphA10 mAb Ea10Mab-2 (mouse IgG1, kappa)	specific for human EphA10 established by CBIS method	FACS
anti-EphA10 mAb Ea10Mab-3 (mouse IgG1, kappa)	specific for human EphA10 established by CBIS method	FACS
anti-EphA10 mAb Ea10Mab-4 (mouse IgG1, kappa)	specific for human EphA10 established by CBIS method	FACS

Back to list

EphB1	Character	Application	Ref	Gene cloning
anti-EphB1 mAb Eb1Mab-1 (mouse IgG1, kappa)	specific for human EphB1 Kd: 4.1 x 10^-9 M	FACS	in preparation (Yamamoto et al)	done
anti-EphB1 mAb Eb1Mab-2 (mouse IgM, kappa)	specific for human EphB1	FACS
anti-EphB1 mAb Eb1Mab-3 (mouse IgG1, kappa)	specific for human EphB1 Kd: 2.5 x 10^-9 M	FACS

Back to list

EphB2	Character	Application	Ref	Gene cloning	Company
anti-EphB2 mAb Eb2Mab-1 (mouse IgG1, kappa)	specific for human EphB2; Kd: 5.9 x 10^-9 for CHO/hEphB2; ref: clone 2H9 (BD; 3.4 x 10^-9 for CHO/hEphB2; Kd: 1.9 x 10^-9 for LS174T)	FACS
anti-EphB2 mAb Eb2Mab-2 (mouse IgG1, kappa)	specific for human EphB2; Kd: 6.4 x 10^-9 for CHO/hEphB2	FACS
anti-EphB2 mAb Eb2Mab-3 (mouse IgG1, kappa)	specific for human EphB2; Kd: 1.1 x 10^-9 for CHO/hEphB2; 3.6 x 10^-10 for LS174T	FACS	Eb2Mab-3	done
anti-EphB2 mAb Eb2Mab-4 (mouse IgG1, kappa)	specific for human EphB2; Kd: 3.3 x 10^-9 for CHO/hEphB2	FACS
anti-EphB2 mAb Eb2Mab-5 (mouse IgG3, kappa)	specific for human EphB2	FACS
anti-EphB2 mAb Eb2Mab-6 (mouse IgM, kappa)	specific for human EphB2	FACS
anti-EphB2 mAb Eb2Mab-7 (mouse IgG1, kappa)	specific for human EphB2; Kd: 5.2 x 10^-9 for CHO/hEphB2	FACS
anti-EphB2 mAb Eb2Mab-8 (mouse IgG1, kappa)	specific for human EphB2; Kd: 9.5 x 10^-9 for CHO/hEphB2	FACS
anti-EphB2 mAb Eb2Mab-9 (mouse IgM, kappa)	specific for human EphB2	FACS
anti-EphB2 mAb Eb2Mab-10 (mouse IgG1, kappa)	specific for human EphB2; Kd: 3.4 x 10^-9 for CHO/hEphB2	FACS
anti-EphB2 mAb Eb2Mab-11 (mouse IgM, kappa)	specific for human EphB2	FACS
anti-EphB2 mAb Eb2Mab-12 (mouse IgG1, kappa)	specific for human EphB2; Kd: 1.7 x 10^-9 for CHO/hEphB2; 4.4 x 10^-10 for LS174T	FACS
EphB2	Character	Application	Ref	Gene cloning	Company
anti-EphB2 mAb Eb2Mab-3-mG2a-f (mouse IgG2a, kappa)	mouse IgG2a version of Eb2Mab-3	FACS		done

Back to list

EphB3	Character	Application	Ref
anti-EphB3 mAb Eb3Mab-1 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method; ref: clone 647354 (R&D)	FACS (LS174T)	in preparation (Li et al)
anti-EphB3 mAb Eb3Mab-2 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-3 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-4 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-5 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS, WB
anti-EphB3 mAb Eb3Mab-6 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-7 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-9 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-10 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-11 (mouse IgG1, kappa)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-12 (mouse Ig)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-13 (mouse Ig)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-14 (mouse Ig)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-15 (mouse Ig)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-16 (mouse Ig)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-17 (mouse Ig)	specific for human EphB3 by CBIS method	FACS
anti-EphB3 mAb Eb3Mab-18 (mouse Ig)	specific for human EphB3 by CBIS method	FACS

Back to list

EphB4	Character	Application	Ref	Gene cloning	Company
anti-EphB4 mAb (Eb4Mab-1, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method ref: clone ab279601 (abcam)	FACS, WB
anti-EphB4 mAb (Eb4Mab-2, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS
anti-EphB4 mAb (Eb4Mab-3, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS, WB
anti-EphB4 mAb (Eb4Mab-4, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS, WB
anti-EphB4 mAb (Eb4Mab-5, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS, WB
anti-EphB4 mAb (B4Mab-7, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS, WB, IHC	B4Mab-7	done
anti-EphB4 mAb (Eb4Mab-8, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS, WB
anti-EphB4 mAb (Eb4Mab-9, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS, WB, IHC
anti-EphB4 mAb (Eb4Mab-10, mouse IgG1, kappa)	specific for human EphB4 established by CBIS method	FACS
EphB4	Character	Application	Ref	Gene cloning	Company
anti-EphB4 mAb (Eb4Mab-7-mG2a-f, mouse IgG2a, kappa)	mouse IgG2a version of B4Mab-7	FACS, WB, IHC		done

Back to list

EphB6	Character	Application	Ref	Gene cloning
anti-EphB6 mAb Eb6Mab-1 (mouse IgG1,kappa)	specific for human EphB6; established by CBIS method; ref: clone T49-25 (BioLegend; Kd: 1.3 x 10^-8 M for DLD-1; 1.5 x 10^-8 M for CHO/EphB6)	FACS
anti-EphB6 mAb Eb6Mab-2 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method Kd: 8.7 x 10^-9 M for CHO/hEphB6	FACS
anti-EphB6 mAb Eb6Mab-3 (mouse IgG1, kappa)	specific for human EphB6; established by CBIS method ; >Kd: 2.0 x 10^-9 M for DLD-1; 3.8 x 10^-8 M for CHO/EphB6	FACS, WB	in preparation (Kaneko et al)	done
anti-EphB6 mAb Eb6Mab-4 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method< 3.6 x 10^-9 M for CHO/EphB6	FACS
anti-EphB6 mAb Eb6Mab-5 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-6 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method 3.7 x 10^-9 M for CHO/EphB6	FACS
anti-EphB6 mAb Eb6Mab-7 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method 3.0 x 10^-9 M for CHO/EphB6	FACS
anti-EphB6 mAb Eb6Mab-8 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method 2.5 x 10^-9 M for CHO/EphB6	FACS
anti-EphB6 mAb Eb6Mab-9 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-10 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-11 (mouse IgM, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-12 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-13 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-14 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-15 (mouse IgG1, lambda)	specific for human EphB6 established by CBIS method 8.4 x 10^-9 M for CHO/EphB6	FACS
anti-EphB6 mAb Eb6Mab-16 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-17 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-18 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-19 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-20 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS, WB (weak)
anti-EphB6 mAb Eb6Mab-21 (mouse IgG2b, kappa)	specific for human EphB6 established by CBIS method 7.5 x 10^-8 M for CHO/EphB6	FACS, WB (weak)
anti-EphB6 mAb Eb6Mab-22 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-23 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method Kd: 3.0 x 10^-8 M for CHO/hEphB6	FACS
anti-EphB6 mAb Eb6Mab-24 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method Kd: 3.8 x 10^-8 M for CHO/hEphB6	FACS
anti-EphB6 mAb Eb6Mab-25 (mouse IgG1 or G2b, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-26 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-29 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-30 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method 5.8 x 10^-9 M for CHO/EphB6	FACS
anti-EphB6 mAb Eb6Mab-31 (mouse IgG1, kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-32 (mouse IgG1 (G2b), kappa)	specific for human EphB6 established by CBIS method	FACS
anti-EphB6 mAb Eb6Mab-33 (mouse IgG1 (G2b), kappa)	specific for human EphB6 established by CBIS method	FACS

Back to list

GM3	Character	Application	Ref	Gene cloning	Company
anti-GM3 mAb (DH2-mG1, mouse IgG1, kappa)	specific for human GM3	FACS	DH2	done

Back to the list

GPC1	Character	Application	Ref
anti-GPC1 mAb (G1Mab-1, mouse IgG2a, kappa)	specific for human GPC1 Kd: 4.5 x 10^-8 p.c.: 1019718 (R&D; Kd: 6.3 x 10^-8)	FACS
anti-GPC1 mAb (G1Mab-2, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-3, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-4, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-5, mouse IgG2b, kappa)	specific for human GPC1 Kd: 3.5 x 10^-8	FACS, IHC
anti-GPC1 mAb (G1Mab-6, mouse IgG2b, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-7, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-8, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-9, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-10, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-11, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-12, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-13, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-14, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-15, mouse IgG1)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-16, mouse IgG2a, kappa)	specific for human GPC1 Kd: 1.4 x 10^-7	FACS, WB
anti-GPC1 mAb (G1Mab-17, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-18, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-19, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-20, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-21, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-22, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-23, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-24, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-25, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-26, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-27, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-28, mouse IgG1, kappa)	specific for human GPC1 Kd: 3.3 x 10^-8	FACS, WB, IHC	in preparation (Yamamoto et al)
anti-GPC1 mAb (G1Mab-29, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-30, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-31, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-32, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-33, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-34, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-35, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-36, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-37, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-38, mouse IgG1, kappa)	specific for human GPC1	FACS, WB
anti-GPC1 mAb (G1Mab-39, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-40, mouse IgG1, kappa)	specific for human GPC1	FACS
anti-GPC1 mAb (G1Mab-41, mouse IgG1, kappa)	specific for human GPC1	FACS, WB

Back to list

GPC2	Character	Application	Ref
anti-GPC2 mAb (G2Mab-1, mouse IgG2a, kappa)	specific for human GPC2; control: CST (Cat#90488); Kd: 1.3 x 10^-8 cell line: IMR-32	FACS
anti-GPC2 mAb (G2Mab-2, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-3, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-4, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-5, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-6, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-7, mouse IgG1, kappa)	specific for human GPC2 Kd: 2.3 x 10^-8	FACS, WB, IHC	in preparation (Ishikawa et al)
anti-GPC2 mAb (G2Mab-8, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-9, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-10, mouse IgG2b, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-11, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-12, mouse IgG1, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-13, mouse IgG2a, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-14, mouse IgG2a, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-16, mouse IgG2a, kappa)	specific for human GPC2	FACS
anti-GPC2 mAb (G2Mab-17, mouse IgG1, kappa)	specific for human GPC2	FACS

Back to list

GPC3	Character	Application	Ref	Gene cloning	Company
anti-GPC3 mAb (G3Mab-4; mouse IgM, kappa)	specific for human GPC3	FACS, WB	in preparation	done
anti-GPC3 mAb (G3Mab-7; mouse IgG1, kappa)	specific for human GPC3	FACS		done
anti-GPC3 mAb (G3Mab-8; mouse IgG2a, kappa)	specific for human GPC3	FACS		done
GPC3	Character	Application	Ref	Gene cloning	Company
anti-GPC3 mAb (G3Mab-4-mG1; mouse IgG1, kappa)	specific for human GPC3	FACS, WB		done
anti-GPC3 mAb (G3Mab-4-mG2a; mouse IgG2a, kappa)	specific for human GPC3	FACS, WB		done
anti-GPC3 mAb (humG3Mab-4; human IgG1, kappa)	specific for human GPC3	FACS, WB		done
anti-GPC3 mAb (humG3Mab-4-scFv-hG1)	specific for human GPC3	FACS, WB		ongoing
anti-GPC3 mAb (humG3Mab-7; human IgG1, kappa)	specific for human GPC3	FACS		done
anti-GPC3 mAb (humG3Mab-7-scFv-Fc)	specific for human GPC3	FACS		ongoing
anti-GPC3 mAb (G3Mab-8-scFv-Fc)	specific for human GPC3	FACS		ongoing

Back to list

GPC4	Character	Application	Ref
anti-GPC4 mAb (G4Mab-1, mouse IgM, kappa)	specific for human GPC4; pc: clone A21050B (BioLegend); endo (KYSE2710, HepG2, OUR-10, COLO201, COLO205, LS174T, MDA-MB-231, Lu65, 293FT)	FACS	in preparatin (Li et al)
anti-GPC4 mAb (G4Mab-2, mouse IgG1, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-3, mouse IgG1, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-4, mouse IgM, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-5, mouse IgG1, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-6, mouse IgG1, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-7, mouse IgG1, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-8, mouse IgG1, kappa)	specific for human GPC4	FACS
anti-GPC4 mAb (G4Mab-9, mouse Ig)	specific for human GPC4	FACS, WB
anti-GPC4 mAb (G4Mab-10, mouse Ig)	specific for human GPC4	FACS

Back to list

GPC5	Character	Application
anti-GPC5 mAb (G5Mab-1, mouse IgG1, kappa)	GPC5 expression in cancer cells (KYSE2710, Lu65, OUR-10, HepG2, MDA-MB-231) is very low. positive control: R&D, clone:297716	FACS, WB
anti-GPC5 mAb (G5Mab-2, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-3, mouse IgG2b, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-4, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-5, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-6, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-7, mouse IgG2b, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-8, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-9, mouse IgG1, kappa)	specific for human GPC5	FACS, WB
anti-GPC5 mAb (G5Mab-10, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-11, mouse IgG1, kappa)	specific for human GPC5	FACS, WB
anti-GPC5 mAb (G5Mab-12, mouse IgG2b, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-13, mouse IgG2b, kappa)	specific for human GPC5	FACS, WB
anti-GPC5 mAb (G5Mab-14, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-15, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-16, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-17, mouse IgG1, kappa)	specific for human GPC5	FACS
anti-GPC5 mAb (G5Mab-18, mouse IgG1, kappa)	specific for human GPC5	FACS

Back to list

GPC6	Character	Application	Ref
anti-GPC6 mAb (G6Mab-1, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-2, mouse IgG2a, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-3, mouse IgM, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-4, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-5, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-6, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-7, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-8, mouse IgG3, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-9, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-10, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-11, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-12, mouse IgG1, kappa)	specific for human GPC6	FACS
anti-GPC6 mAb (G6Mab-13, mouse IgG1, kappa)	specific for human GPC6	FACS, WB	in preparatin (Yamamoto et al)

Back to list

TROP2	Character	Application	Ref	Gene cloning	Company
anti-TROP2 mAb (TrMab-6; mouse IgG2b, kappa)	specific for human TROP2; (ref: TNBC)	IHC, WB, FACS	TrMab-6 MCF7 TNBC	done	exbio
anti-TROP2 mAb (TrMab-29; mouse IgG1, kappa)	specific for human TROP2	IHC, WB, FACS	TrMab-29	done	merck
anti-TROP2 mAb (Datopotamab; humanized IgG1, kappa)	Humanized mAb for DS-1062/Dato-DXd (Daiichi-Sankyo)	FACS		done
anti-TROP2 mAb (Sacituzumab; humanized IgG1, kappa)	Humanized mAb (Sacituzumab govitecan; Trodelvy)	FACS		done

Back to list

HGF	Character	Application	Ref	Gene cloning	Company
anti-HGF mAb (t8E4; mouse IgG1, kappa)	specific for active HGF	WB, IHC	SREP IJMS	done	Merck
anti-HGF mAb (t5A11; mouse IgG1, kappa)	specific for HGF	WB, IHC	SREP IJMS	done
anti-HGF mAb (t1E4; mouse IgG2b, kappa)	specific for HGF	neutralization	SREP	done

Back to list

Podocalyxin	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb (PcMab-47; mouse IgG1, kappa)	specific for human PODXL	FACS, WB, IHC	PcMab-47 IHC_OSCC epitope	done	APRO abcam exbio
Podocalyxin	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb (47-mG2a; mouse IgG2a, kappa)	IgG2a version of PcMab-47; specific for human PODXL	FACS, WB, IHC; ADCC/CDC, antitumor activities	47-mG2a IHC_LK IHC_EC	done
anti-PODXL mAb (47-mG2a-f; mouse IgG2a, kappa)	core fucose-deficient IgG2a version of PcMab-47; specific for human PODXL	FACS, WB, IHC; ADCC/CDC, antitumor activities	47-mG2a-f	done
anti-PODXL mAb (chPcMab-47; human IgG1)	specific for human PODXL	FACS, WB, IHC	chPcMab-47	done

Back to list

human podoplanin	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (NZ-1; rat IgG2a, lambda)	specific for human PDPN	IP, IHC, WB, FACS (Review; patent)	NZ-1	done	APRO
anti-hPDPN mAb (NZ-1.2; rat IgG2a)	specific for human PDPN; the other clones: NZ-1.3(Thermo), NC-08 (BioLegend)	IP, IHC, WB, FACS	NZ-1.2	done	Merck,MBL,Novus, Zenogen,Wako
anti-hPDPN mAb (LpMab-2; mouse IgG1, kappa)	CasMab	IHC, WB, FACS	Cells2022 LpMab-2 patent	done
anti-hPDPN mAb (LpMab-3; mouse IgG1, kappa)	specific for human PDPN; epitope: Thr76	IHC, WB, FACS	LpMab-3 epitope Structure	done	MCP
anti-hPDPN mAb (LpMab-7 ;mouse IgG1, kappa)	specific for human PDPN	IHC, WB, FACS	LpMab-7 OS epitope	done	abcam MCP zenogen
anti-hPDPN mAb (LpMab-9; mouse IgG1, kappa)	specific for human PDPN; epitope: Thr25	WB, FACS	LpMab-9 epitope	done	MCP
anti-hPDPN mAb (LpMab-10; mouse IgG3, kappa)	specific for human PDPN; epitope: PLAG1 Thr34	IHC, WB, FACS	LpMab-10	done
anti-hPDPN mAb (LpMab-12; mouse IgG1, kappa)	specific for human PDPN; epitope: PLAG3 Thr52	IHC, WB, FACS	LpMab-12	done	APRO; CST Merck Hycult MCP, zenogen
anti-hPDPN mAb (LpMab-13; mouse IgG1, kappa)	specific for human PDPN; epitope: PLAG2-3	IHC, WB, FACS	LpMab-13	done	Merck Hycult
anti-hPDPN mAb (LpMab-16; mouse IgG1, kappa)	specific for human PDPN	IHC, WB, FACS	patent 2018-123699	done
anti-hPDPN mAb (LpMab-17; mouse IgG1, kappa)	specific for human PDPN	IHC, WB, FACS press release	LpMab-17	done	BD Merck Hycult
anti-hPDPN mAb (LpMab-19; mouse IgG2b, kappa)	specific for human PDPN; epitope: Thr76	IHC, WB, FACS, ADCC/CDC	LpMab-19	done	Merck
anti-hPDPN mAb (LpMab-21; mouse IgG2a, kappa)	specific for human PDPN; epitope: Thr76	IHC, WB, FACS, ADCC/CDC press release	Cells2022 LpMab-21 in vivo	done	Merck BioLegend MCP
anti-hPDPN mAb (LpMab-23; mouse IgG1, kappa)		IHC, WB, FACS	YouTube LpMab-23 IHC patent	done	BD exbio
human podoplanin	Character	Application	Ref	Gene cloning	Company
anti-human PDPN mAb (NZ-8; human IgG1, kappa)	specific for human PDPN; rat-human chimeric mAb originated from NZ-1	IP, IHC, WB, FACS	NZ-8	done
anti-human PDPN mAb (NZ-12; human IgG1, lambda)	specific for human PDPN; rat-human chimeric mAb originated from NZ-1	IP, IHC, WB, FACS	NZ-12 RIT	done
anti-human PDPN mAb (NZ-16; human IgG1, lambda)	specific for human PDPN; rat-human chimeric mAb originated from NZ-1	IP, IHC, WB, FACS	RIT	done
anti-human PDPN mAb (NZ-27; human IgG1, lambda)	specific for human PDPN; humanized mAb originated from NZ-1	IP, IHC, WB, FACS	NZ-27 CAR-T	done
anti-human PDPN mAb (chLpMab-7; human IgG1)	specific for human PDPN; mouse-human chimeric mAb originated from LpMab-7	IHC, WB, FACS	chLpMab-7	done

Back to list

mouse podoplanin	Character	Application	Ref	Gene cloning	Company
anti mouse PDPN mAb (PMab-1; rat IgG2a, kappa)	specific for mouse PDPN --> anti-human PDPN	IHC, WB, FACS	PMab-1 PMab-1_LEC epitope	done	abcam; MBL; Nov; Mer; BioL; BD
anti-mouse PDPN mAb (mPMab-1; mouse IgG2a,kappa)	specific for mouse PDPN	IHC, WB, FACS	mPMab-1	done
anti-mouse PDPN mAb (PMab-1-mG2a-f; mouse IgG2a,kappa)	specific for mouse PDPN	IHC, WB, FACS		done
rat podoplanin	Character	Application	Ref	Gene cloning	Company
anti-rat PDPN mAb (PMab-2; mouse IgG1, kappa)	specific for rat PDPN	IHC, WB, FACS	PMab-2 PMab-2_epitope	done	abcam Merck BioLegend
rabbit podoplanin	Character	Application	Ref	Gene cloning	Company
anti-rabbit PDPN mAb (PMab-32; mouse IgG1, kappa)	specific for rabbit PDPN	IHC, WB, FACS	PMab-32 epitope
dog podoplanin	Character	Application	Ref	Gene cloning	Company
anti-dog PDPN mAb (PMab-38; mouse IgG1, kappa)	specific for dog PDPN	IHC, WB, FACS	PMab-38; SCC melanoma epitope	done	zenogen Wako
anti-dog PDPN mAb (P38Bf; dog IgGB, kappa)	core fucose-deficient type B of PMab-38	IHC, WB, FACS	P38Bf P38B_in vivo ADC	done
anti-dog PDPN mAb (PMab-48; mouse IgG1, kappa)	specific for dog PDPN	IHC, WB, FACS	PMab-48 epitope	done	zenogen
bovine podoplanin	Character	Application	Ref	Gene cloning	Company
anti-bovPDPN mAb (PMab-44; mouse IgG1, kappa)	specific for bovine PDPN	IHC, WB, FACS	PMab-44; epitope goat; sheep; alpaca	done	zenogen
cat podoplanin	Character	Application	Ref	Gene cloning	Company
anti-cat PDPN mAb (PMab-52; mouse IgM, kappa)	specific for cat PDPN	IHC, WB, FACS	PMab-52; epitope IHC-1; IHC-2 tiger PDPN	done	zenogen
tiger podoplanin	Character	Application	Ref	Gene cloning	Company
anti-tiger PDPN mAb (PMab-231; mouse IgG2a, kappa)	specific for tiger PDPN	IHC, WB, FACS	PMab-231 epitope; lion	done	zenogen
tiger podoplanin	Character	Application	Ref	Gene cloning	Company
anti-tiger PDPN mAb (PMab-231-f; mouse IgG2a, kappa)	defucosylation of PMab-231	isotype control of mouse IgG2a in vivo	250_in vivo	done	zenogen
horse podoplanin	Character	Application	Ref	Gene cloning	Company
anti-horse PDPN mAb (PMab-219; mouse IgG2a, kappa)	specific for horse PDPN	WB, FACS, IHC	PMab-219 epitope	done	zenogen
anti-horse PDPN mAb (PMab-202; mouse IgG1, kappa)	specific for horse PDPN	WB, FACS	PMab-202 epitope	done	zenogen
pig podoplanin	Character	Application	Ref	Gene cloning	Company
anti-pig PDPN mAb (PMab-213; mouse IgG2b, kappa)	specific for pig PDPN	WB, FACS, IHC	PMab-213 epitope LEC	done	zenogen
anti-pig PDPN mAb (PMab-210; mouse IgG1, kappa)	specific for pig PDPN	WB, FACS, IHC	PMab-210 epitope	done	zenogen
goat podoplanin	Character	Application	Ref	Gene cloning	Company
anti-goat PDPN mAb (PMab-235; mouse IgG1, kappa)	specific for goat PDPN	IHC, WB, FACS	PMab-235 epitope	done	zenogen
alpaca podoplanin	Character	Application	Ref	Gene cloning	Company
anti-aPDPN mAb (PMab-225; mouse IgG2b, kappa)	specific for alpaca PDPN	IHC, WB, FACS	PMab-225 epitope	done	zenogen
Tas_devil podoplanin	Character	Application	Ref	Gene cloning	Company
anti-TasPDPN PDPN (PMab-233; mouse IgG1, kappa)	specific for Tasmanian devil PDPN	IHC, WB, FACS	PMab-233 epitope	done	zenogen
bear podoplanin	Character	Application	Ref	Gene cloning	Company
anti-bear PDPN mAb (PMab-241; mouse IgG2b, kappa)	specific for bear PDPN	IHC, WB, FACS	PMab-241 epitope
anti-bear PDPN mAb (PMab-247; mouse IgG1, kappa)	specific for bear PDPN	IHC, WB, FACS	PMab-247 IHC epitope	done	zenogen
whale podoplanin	Character	Application	Ref	Gene cloning	Company
anti-whale PDPN mAb (PMab-237; mouse IgG1, kappa)	specific for whale PDPN	IHC, WB, FACS	PMab-237 IHC epitope	done	zenogen
sheep podoplanin	Character	Application	Ref	Gene cloning	Company
anti-sheep PDPN mAb (PMab-256; mouse IgG1, kappa)	specific for sheep PDPN	IHC, WB, FACS	PMab-256 epitope	done	zenogen
anti-sheep PDPN mAb (PMab-253; mouse IgM, kappa)	specific for sheept PDPN	IHC, WB, FACS	PMab-253	done
anti-sheep PDPN mAb (PMab-260; mouse IgM, kappa)	specific for sheep PDPN	IHC, WB, FACS	PMab-260	done
sea lion podoplanin	Character	Application	Ref	Gene cloning	Company
anti-seaPDPN mAb (PMab-269; mouse IgG1, kappa)	specific for sea lion PDPN	IHC, WB, FACS	PMab-269 epitope Steller Sea Lion	done
elephant podoplanin	Character	Application	Ref	Gene cloning	Company
anti-elePDPN mAb (PMab-265; mouse IgM, kappa)	specific for elephant PDPN	FACS	PMab-265
anti-elePDPN mAb (PMab-295; mouse IgG1, kappa)	specific for elephant PDPN	FACS, WB, IHC	PMab-295 epitope	done	Ab.antibody
ferret podoplanin	Character	Application	Ref	Gene cloning	Company
anti-ferret PDPN mAb (PMab-241; mouse IgG2b, kappa)	anti-bear PDPN mAb crossreacts with ferret PDPN	IHC, WB, FACS	PMab-241
anti-ferret PDPN mAb (PMab-292; mouse IgG1, kappa)	specific for ferret PDPN	IHC, WB, FACS	PMab-292 epitope	done	Ab.antibody
anti-ferret PDPN mAb (PMab-293; mouse IgM, kappa)	specific for ferret PDPN	FACS, WB
hamster podoplanin	Character	Application	Ref	Gene cloning	Company
anti-hamPDPN mAb (PMab-281; mouse IgG3, kappa)	specific for hamster PDPN	FACS, IHC	PMab-281 epitope	done
anti-hamPDPN mAb (281-mG2a; mouse IgG2a, kappa)	specific for hamster PDPN; IgG2a version of PMab-281	FACS, IHC	281-mG2a epitope	done
anti-hamPDPN mAb (281-mG2a-f; mouse IgG2a, kappa)	defucocylated 281-mG2a	isotype control of mouse IgG2a in vivo	H2Mab-214 H2Mab-77	done
giraffe podoplanin	Character	Application	Ref	Gene cloning	Company
anti-girPDPN mAb (PMab-301; mouse IgG1, kappa)	specific for giraffe PDPN Kd: 1.3 x 10-8 M	FACS, WB, IHC	PMab-301
panda podoplanin	Character	Application	Ref	Gene cloning	Company
anti-panPDPN mAb (PMab-314; mouse IgG1, kappa)	specific for panda PDPN Kd: 1.3 x 10-8 M	FACS, WB	PMab-314
rhinoceros podoplanin	Character	Application	Ref	Gene cloning	Company
anti-rhiPDPN mAb (PMab-315; mouse IgG2a, kappa)	specific for rhinoceros PDPN	FACS, WB	Ubukata et al
hippopotamus podoplanin	Character	Application	Ref	Gene cloning	Company
anti-hipPDPN mAb (PMab-316; mouse IgG3(2b), kappa)	specific for hippopotamus PDPN	FACS, WB	Yamamoto et al
anti-hipPDPN mAb (PMab-317; mouse IgG1, kappa)	specific for hippopotamus PDPN	FACS, WB
anti-hipPDPN mAb (PMab-318; mouse IgG1, kappa)	specific for hippopotamus PDPN	FACS, WB
anti-hipPDPN mAb (PMab-319; mouse IgG3(2b), kappa)	specific for hippopotamus PDPN	FACS, WB
anti-hipPDPN mAb (PMab-320; mouse IgG1, kappa)	specific for hippopotamus PDPN	FACS, WB
anti-hipPDPN mAb (PMab-321; mouse IgM, kappa)	specific for hippopotamus PDPN	FACS
anti-hipPDPN mAb (PMab-322; mouse Ig2a, kappa)	specific for hippopotamus PDPN	FACS, WB
anti-hipPDPN mAb (PMab-323; mouse IgM, kappa)	specific for hippopotamus PDPN	FACS

Back to list

intracellular proteins

ATRX	Character	Application	Ref	Gene cloning	Company
anti-ATRX mAb (AMab-6; mouse IgG1, kappa)	specific for human ATRX	IHC, WB	AMab-6 AMab-6_epitope AMab-6_IHC	done	APRO abcam

Back to the list

DGK	Character	Application	Ref	Gene cloning
anti-DGKalpha mAb (DaMab-2; mouse IgG1, kappa)	specifi for DGKalpha	ICC	DaMab-2 epitope	done
anti-DGKalpha mAb (Da2mG2a; mouse IgG2a, kappa)	specifi for DGKalpha	ICC		done
anti-DGKalpha mAb (DaMab-8; mouse IgG1, kappa)	specific for DGKalpha	IHC	DaMab-8	done
anti-DGKalpha mAb (Da8mG2a; mouse IgG2a, kappa)	specific for DGKalpha	ICC, IHC		done
anti-DGKgamma mAb (DgMab-6; mouse IgG1, kappa)	specific for DGKgamma	ICC	DgMab-6 PDF	done
anti-DGKalpha mAb (Dg6mG2a; mouse IgG2a, kappa)	specifi for DGKgamma	ICC		done
anti-DGKzeta mAb (DzMab-1; rat IgG2b, kappa)	specific for DGKzeta	ICC	DzMab-1 epitope	done
anti-DGKzeta mAb (Dz1mG2a; mouse IgG2a, kappa)	specific for DGKzeta	ICC		done
anti-DGKeta mAb (DhMab-1;mouse IgG2c, kappa)	specific for DGKeta	IHC	DhMab-1	done
anti-DGKalpha mAb (Dh1mG2a; mouse IgG2a, kappa)	specifi for DGKeata	ICC		done
anti-DGKeata mAb (DhMab-4; mouse IgG2b, kappa)	specific for DGKeta	IHC	DhMab-4 ICC	done
anti-DGKalpha mAb (Dh4mG2a; mouse IgG2a, kappa)	specifi for DGKeata	ICC		done
anti-DGKdelta mAb (DdMab-1; mouse IgG2c, kappa)	specific for DGKdeta	IHC	DdMab-1	done
anti-DGKalpha mAb (Dd1mG2a; mouse IgG2a, kappa)	specifi for DGKdelta	ICC		done

Back to list

IDH	Character	Application	Ref	Gene cloning	Company
anti-IDH1-R132H mAb (HMab-1; mouse IgG1, kappa)	specific for IDH1-R132H	IHC, WB	HMab-1	done	APRP; Merck MBL; IBL; Sigma
anti-IDH1-R132H mAb (HMab-2; mouse IgG1, kappa)	specific for IDH1-R132H	IHC, WB	HMab-2	done	abcam
anti-IDH1-R132S mAb (SMab-1; mouse IgG1, kappa)	specific for IDH1-R132S	IHC, WB	SMab-1	done	APRO; abcam IBL; MBL Merck_Sigma
anti-IDH1-R132G mAb (GMab-r1; rat IgG2a, kappa)	specific for IDH1-R132G	IHC, WB	GMab-r1	done	abcam MBL
anti-IDH2-R172K mAb (KMab-1; rat IgG2b, kappa)	specific for IDH2-R172K	IHC, WB isotype control of rat IgG2b	KMab-1	done	abcam MBL
anti-IDH2-R172M mAb (MMab-1; rat IgG2b, kappa)	specific for IDH2-R172M	IHC, WB	MMab-1	done	abcam
anti-IDH2-R172W mAb (WMab-1; rat IgG2b, kappa)	specific for IDH2-R172W	IHC, WB	WMab-1	done	abcam MBL
anti-IDH2-R172S mAb (SMab-2; mouse IgG1, kappa)	specific for IDH2-R172S	IHC, WB	SMab-2	done	abcam
anti-IDH1 mAb (RMab-3; mouse IgG1, kappa)	specific for IDH1	IHC, WB	RMab-3	done	BD MBL
anti-IDH1 mAb(RcMab-1; rat IgG2a, kappa)	specific for IDH1	IHC, WB isotype control of rat IgG2a	RcMab-1	done	abcam CST MBL
anti-IDH2 mAb (RMab-22; mouse IgG2b, kappa)	specific for IDH2	IHC, WB	RMab-22	done	MBL
anti-IDH2 mAb (KrMab-3; mouse IgG2b, kappa)	specific for IDH2	IHC, WB	KrMab-3	done	CST BioLegend MBL
anti-mIDH1/2 mAb (MsMab-1; mouse IgG1, kappa)	specific for mutated IDH1/2	IHC, WB (ref)	TJEM Brain Tumor Pathol Cancer Med	done	abcam Merck
anti-mIDH1/2 mAb (MsMab-2; rat IgG2a, kappa)	specific for mutated IDH1/2	IHC, WB	MsMab-2	done	MBL

Back to list

TERT	Character	Application	Ref	Gene cloning	Company
anti-mTERT mAb (TmMab-1; rat IgG1, kappa)	specific for mTERT	ELISA, WB isotype control of rat IgG1		done
anti-mTERT mAb (TmMab-2; rat IgG2a, kappa)	specific for mTERT	ELISA isotype control of rat IgG2a		done
anti-mTERT mAb (TmMab-3; rat IgG1, kappa)	specific for mTERT	ELISA, WB		done
anti-mTERT mAb (TmMab-4; rat IgG1, kappa)	specific for mTERT	ELISA		done
anti-hTERT mAb (TpMab-1; mouse IgG1, kappa)	specific for phosphorylated threonine 249 of hTERT	IHC, WB, ELISA	TpMab-1 (press) NCB	done
anti-hTERT mAb (TpMab-2; mouse IgG1, kappa)	specific for phosphorylated threonine 249 of hTERT	IHC, WB, ELISA		done
anti-hTERT mAb (TpMab-3; mouse IgG1, kappa)	specific for phosphorylated threonine 249 of hTERT	IHC, WB, ELISA	TpMab-3 (press) NCB	done	Merck
anti-hTERT mAb (TpMab-35; mouse IgG1, kappa)	specific for phosphorylated threonine 249 of hTERT	ICC, WB, ELISA	TpMab-35
anti-hTERT mAb (TwMab-1; mouse IgG1, kappa)	specific for hTERT	IHC, WB, ELISA	TwMab-1	done	Merck
anti-hTERT mAb (TMab-6; mouse IgM, kappa)	specific for hTERT	IHC	TMab-6 TMab-6_epitope	done

Back to list

Monoclonal antibodies for SARS-CoV-2

SARS-CoV-2 (S1 RBD)	Character	Application	Ref	Gene cloning
anti-SARS-CoV-2 S1-RBD mAb (CvMab-1; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 319-338 aa RBD: Receptor binding domain	ELISA,WB, IHC		done
anti-SARS-CoV-2 S1-RBD mAb (CvMab-2; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, WB, IHC, neutralization
anti-SARS-CoV-2 S1-RBD mAb (CvMab-3; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 469-478 aa	ELISA,WB, IHC, neutralization
anti SARS-CoV-2 S1-RBD mAb (CvMab-6; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, WB, IHC, neutralization	CvMab-6	done
anti-SARS-CoV-2 S1-RBD mAb (CvMab-7; mouse IgM, kappa)	specific for SARS-CoV-2 S1-RBD epitope:459-478 aa	ELISA, WB, IHC, neutralization		done
anti-SARS-CoV-2 S1-RBD mAb (CvMab-13; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, WB, IHC		done
anti-SARS-CoV-2 S1-RBD mAb (CvMab-17; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, WB, neutralization, IHC
anti-SARS-CoV-2 S1-RBD mAb (CvMab-18; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, WB, neutralization, IHC
anti-SARS-CoV-2 S1-RBD mAb (CvMab-24; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, WB, IHC, neutralization
anti-SARS-CoV-2 S1-RBD mAb (CvMab-25; mouse IgG1, kappa)	specific for SARS-CoV-2 S1-RBD epitope: 459-478 aa	ELISA, IHC, WB

Back to list

SARS-CoV-2 (S1 N terminus)	Character	Application	Ref	Gene cloning	Company
anti-SARS-CoV-2 mAb (CvMab-32; mouse IgG2b, kappa)	specific for SARS-CoV-2 S1N terminus	ELISA, IHC, WB

Back to list

SARS-CoV-2 (S2)	Character	Application	Ref	Gene cloning
anti-SARS-CoV-2 mAb (CvMab-36; mouse IgG1, kappa)	specific for SARS-CoV-2 S2	ELISA, WB
anti-SARS-CoV-2 mAb (CvMab-62; mouse IgG1, kappa)	specific for SARS-CoV-2 S2	ELISA isotype control of mouse IgG1	CvMab-62	done
anti-SARS-CoV-2 mAb (CvMab-6-Fab; mouse Fab, kappa)	specific for SARS-CoV-2 S2	ELISA		done
anti-SARS-CoV-2 mAb (humCvMab-62; human IgG1, kappa)	specific for SARS-CoV-2 S2	ELISA isotype control of human IgG1		done

Back to list

SARS-CoV-2 (bi-specific)	Character	Ref	Gene cloning
anti-SARS-CoV-2 mAb (CvMab-bis1)	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-6-H_CvM62scFv	CvMab-bis1	done
anti-SARS-CoV-2 mAb (CvMab-bis2)	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-6-L_CvM62scFv	CvMab-bis2	done
anti-SARS-CoV-2 mAb (CvMab-bis3)	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-62-H_CvM6scFv	CvMab-bis3	done
anti-SARS-CoV-2 mAb (CvMab-bis4)	specific for SARS-CoV-2 S1+S2 bispecific mAb CvMab-62-L_CvM6scFv	CvMab-bis4	done
CvMab-62-H_Bebtelovimab-scFv (bispecific)	specific for SARS-CoV-2 S1+S2	Bebtelovimab	done
humCvMab-62-H_Bebtelovimab-scFv (bispecific)	specific for SARS-CoV-2 S1+S2	Bebtelovimab	done
CvMab-62-H_Cilgavimab-scFv (bispecific)	specific for SARS-CoV-2 S1+S2		done

Back to list

SARS-CoV-2 (humanized)	Character	Application	Ref	Gene cloning
Bebtelovimab (human IgG1, lambda)	specific for SARS-CoV-2 S1 (sequence) (Lancet)	Neutralization; weak activity for all variants	Bebtelovimab	done
Cilgavimab (human IgG1, kappa)	specific for SARS-CoV-2 S1 (sequence) (Lancet) Cilgavimab plus tixagevimab (EVUSHELD)	Neutralization; weak activity for BA.2; resistant for BA.4/5		done
Casirivimab (human IgG1, kappa)	specific for SARS-CoV-2 S1 (sequence) (Lancet) Casirivimab plus imdevimab (Ronapreve)	Neutralization; weak activity for Omicron		done
Bamlanivimab (human IgG1, kappa)	specific for SARS-CoV-2 S1 (sequence) (Lancet)	Neutralization; no activity for Omicron		done
Bebtelovimab-scFv (scFv-Fc of human IgG1)	specific for SARS-CoV-2 S1		Bebtelovimab	done
Cilgavimab-scFv (scFv-Fc of human IgG1)	specific for SARS-CoV-2 S1			done

Back to list

RdRP	Character	Application	Ref	Gene cloning
anti-RdRP mAb (RdMab-2; mouse IgG2a, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV	ELISA, WB, IP, ICC	RdMab-2	done
anti-RdRP mAb (RdMab-13; mouse IgM, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV	ELISA, WB isotype control of mouse IgM	RdMab-13	done
anti-RdRP mAb (RdMab-15; mouse IgG1, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP ; Immunogen: RHTFSNYQHEETIYNLLKDC	ELISA, WB	RdMab-15
anti-RdRP mAb (RdMab-16; mouse IgG1, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP ; Immunogen: RHTFSNYQHEETIYNLLKDC	ELISA, WB	RdMab-16
anti-RdRP mAb (RdMab-20; mouse IgG2b, kappa)	specific for SARS-CoV-2 nsp12, catalytic subunit of the RdRP; Immunogen: TRALTAESHVDTDLTKPYIC; distinguishes nsp12 of SARS-CoV-2 from that of SARS-CoV	ELISA, WB isotype control of mouse IgG2b	RdMab-20	done

Back to list

anti-dog protein monoclonal antibodies

dog PDPN	Character	Application	Ref	Gene cloning	Company
anti-dog PDPN mAb (PMab-38; mouse IgG1, kappa)	specific for dog PDPN	IHC, WB, FACS	PMab-38; SCC melanoma epitope	done	zenogen Wako
anti-dog PDPN mAb (P38Bf; dog IgGB, kappa)	core fucose-deficient type B of PMab-38	IHC, WB, FACS	P38Bf P38B_in vivo ADC	done
anti-dog PDPN mAb (PMab-48; mouse IgG1, kappa)	specific for dog PDPN	IHC, WB, FACS	PMab-48 epitope	done	zenogen
dog EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (134-mG2a-f; mouse IgG2a, kappa)	core fucose-deficient mouse IgG2a version of EMab-134; reacts with domain-III	FACS, WB, IHC, ADCC, CDC, antitumor activities	CHO/dEGFR Osteosarcoma Fibroblastic Mammary	done
anti-EGFR mAb (E134Bf; canine IgGB, kappa)	core fucose-deficient canine IgGB version of EMab-134; specific for EGFR	FACS, WB, IHC, ADCC, CDC, antitumor activities	Mammary Fibro & Osteo	done
dog HER2	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H77Bf; canine IgGB, kappa)	core fucose-deficient canine IgGB version of H2Mab-77	FACS, WB, IHC, ADCC/CDC, antitumor activities	H77Bf OS fibro	done
anti-HER2 mAb (H2Mab-41; mouse IgG2b, kappa)	specific for HER2; crossreacts with dog HER2; domain-IV	FACS, antitumor activities	H2Mab-41 dogHER2	done
EGFR-HER2 (bispecific)	Character	Application	Ref	Gene cloning	Company
anti-dog EGFR-dog HER2 mAb (E134B-H77scFv-f)	bispecific mAb for EGFR and HER2	FACS, WB, IHC, ADCC, CDC, antitumor activities	E134B-H77scFv-f	done
dog PD-L1	Character	Application	Ref	Gene cloning	Company
anti-dog PD-L1 mAb (L1Mab-347; mouse IgG1, kappa)	specific for dog PD-L1	FACS, IHC		done
anti-dog PD-L1 mAb (L1Mab-348; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb (L1Mab-349; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb (L1Mab-350; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb (L1Mab-351; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb (L1Mab-352; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-352	done
anti-dog PD-L1 mAb (L1Mab-353; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb (L1Mab-354; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA, IHC	L1Mab-354	done
anti-dog PD-L1 mAb (L1Mab-355; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA
anti-dog PD-L1 mAb (L1Mab-356; mouse IgG1, kappa)	specific for dog PD-L1 (intracellular domain)	ELISA

Back to list

anti-cat protein monoclonal antibodies

cat MET	Character	Application	Ref	Gene cloning	Company
anti-cat MET mAb (cMMab-1; mouse IgG1, kappa)	specific for cat MET (No. 43)	FACS		done
anti-cat MET mAb (cMMab-2; mouse IgG1, kappa)	specific for cat MET (No. 46)	FACS		done
anti-cat MET mAb (cMMab-3; mouse IgG1, kappa)	specific for cat MET (No. 62)	FACS		done
anti-cat MET mAb (cMMab-4; mouse IgG1, kappa)	specific for cat MET (No. 63)	FACS		done
anti-cat MET mAb (cMMab-5; mouse IgG1, kappa)	specific for cat MET (No. 102)	FACS		done
anti-cat MET mAb (cMMab-6; mouse IgG1, kappa)	specific for cat MET (No. 106)	FACS		done
anti-cat MET mAb (cMMab-7; mouse IgG1, kappa)	specific for cat MET (No. 115)	FACS		done
anti-cat MET mAb (cMMab-8; mouse IgG1, kappa)	specific for cat MET (No. 116)	FACS		done
anti-cat MET mAb (cMMab-9; mouse IgG1, kappa)	specific for cat MET (No. 126)	FACS		done
anti-cat MET mAb (cMMab-10; mouse IgG1, kappa)	specific for cat MET (No. 173)	FACS		done
anti-cat MET mAb (cMMab-11; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-12; mouse IgG2b, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-13; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-14; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-15; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-16; mouse IgG2a, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-17; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-18; mouse IgG1, kappa)	specific for cat MET crossreact with human MET	FACS
anti-cat MET mAb (cMMab-19; mouse IgG1, kappa)	specific for cat MET crossreact with human MET	FACS
anti-cat MET mAb (cMMab-20; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-21; mouse IgG2b, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-22; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-23; mouse IgG1, kappa)	specific for cat MET crossreact with human MET	FACS
anti-cat MET mAb (cMMab-24; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-25; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-26; mouse IgG1, kappa)	specific for cat MET crossreact with human MET	FACS
anti-cat MET mAb (cMMab-27; mouse IgG2b, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-28; mouse IgG2b, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-29; mouse IgG2a, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-30; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-31; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-32; mouse IgG2b, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-33; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-34; mouse IgG1, kappa)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-35; mouse Ig)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-36; mouse Ig)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-37; mouse Ig)	specific for cat MET	FACS
anti-cat MET mAb (cMMab-38; mouse Ig)	specific for cat MET	FACS
cat podoplanin	Character	Application	Ref	Gene cloning	Company
anti-cat PDPN mAb (PMab-52; mouse IgM, kappa)	specific for cat PDPN	IHC, WB, FACS	PMab-52; epitope IHC-1; IHC-2 tiger PDPN	done	zenogen
anti-tiger PDPN mAb (PMab-231; mouse IgG2a, kappa)	crossreact with cat PDPN	IHC, WB, FACS	PMab-231 epitope; lion	done	zenogen
anti-tiger PDPN mAb (PMab-231-f; mouse IgG2a, kappa)	defucosylation of PMab-231	isotype control of mouse IgG2a in vivo	250_in vivo	done	zenogen

Back to list

CasMab

PDPN	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (LpMab-2; mouse IgG1, kappa)	CasMab; patent	IHC, WB, FACS	PDPN_review LpMab-2	done	restricted
anti-hPDPN mAb (LpMab-23; mouse IgG1, kappa)		IHC, WB, FACS	YouTube LpMab-23 IHC patent	done	restricted
anti-hPDPN mAb (PMab-117; rat IgM, kappa)		FACS	YouTube PMab-117-mG2a Cells2022	done	restricted
PDPN	Character	Application	Ref	Gene cloning	Company
anti-human PDPN mAb(chLpMab-2; human IgG1, kappa)	CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-2	IP, IHC, WB, FACS	chLpMab-2	done	restricted
anti-human PDPN mAb (chLpMab-23; human IgG1)	CasMab for human PDPN; mouse-human chimeric mAb originated from LpMab-23	IHC, WB, FACS	YouTube chLpMab-23	done	restricted
anti-human PDPN mAb (humLpMab-23-f; human IgG1)	CasMab for human PDPN; humanized mAb originated from LpMab-23	IHC, WB, FACS	YouTube humLpMab-23-f	done	restricted
anti-human PDPN mAb (PMab-117-mG2a-f; mouse IgG2a)	CasMab for human PDPN; mouse IgG2a version of PMab-117	FACS	PMab-117-mG2a	done	restricted
anti-human PDPN mAb (chPMab-117; human IgG1)	CasMab for human PDPN; mouse-human chimeric mAb originated from PMab-117	FACS	YouTube	done	restricted
anti-human PDPN mAb (humPMab-117-f; human IgG1)	CasMab for human PDPN; humanized mAb originated from PMab-117	FACS	YouTube	done	restricted

Back to list

Podocalyxin	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb (PcMab-6; mouse IgG1, kappa)	anti-PODXL CasMab	FACS	PcMab-6 patent	done	restricted
anti-PODXL mAb (PcMab-60; mouse IgM, kappa)	anti-PODXL CasMab	FACS	PcMab-60 epitope patent	done	restricted
Podocalyxin	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb (PcMab-6-mG2a-f; mouse IgG2a)	anti-PODXL CasMab; IgG2a version of PcMab-6	FACS, ADCC/CDC	PcMab-6-mG2a-f	done	restricted
anti-PODXL mAb (PcMab-6-hG1-f; human IgG1)	anti-PODXL CasMab; human IgG1 version of PcMab-6	FACS, ADCC/CDC		done	restricted
anti-PODXL mAb (humPcMab-6-f; human IgG1)	CasMab for PODXL; humanized mAb originated from PcMab-6	FACS	humPcMab-6-f	done	restricted
anti-PODXL mAb (60-mG2a; mouse IgG2a, kappa)	anti-PODXL CasMab; IgG2a version of PcMab-60	FACS, ADCC/CDC	60-mG2a	done	restricted
anti-PODXL mAb (60-mG2a-f; mouse IgG2a, kappa)	anti-PODXL CasMab, core fucose-deficient IgG2a version of PcMab-60	FACS, ADCC/CDC, antitumor activities	60-mG2a-f	done	restricted
anti-PODXL mAb (PcMab-60-hG1-f; human IgG1)	anti-PODXL CasMab; human IgG1 version of PcMab-60	FACS, ADCC/CDC		done	restricted
anti-PODXL mAb (humPcMab-60; human IgG1)	anti-PODXL CasMab; humanized PcMab-60	FACS, ADCC/CDC		done	restricted

Back to list

CD44s	Character	Application	Ref	Gene cloning	Company
anti-CD44s mAb (C44Mab-1012; mouse IgM, kappa)	Mab1 for CD44s (exon-6) cossreact with mouse CD44	FACS		done
anti-CD44s mAb (C44Mab-1075; mouse IgG2a, kappa)	Mab2 for CD44s (exon-6)	FACS		done
anti-CD44s mAb (C44Mab-1095; mouse IgG1, kappa)	Mab3 for CD44s (exon-6)	FACS		done
CD44s	Character	Application	Ref	Gene cloning	Company
anti-CD44s mAb (C44Mab-1012-mG1; mouse IgG1)	Mab1 for CD44s (exon-6)	FACS		done
anti-CD44s mAb (C44Mab-1012-hG1; human IgG1)	Mab1 for CD44s (exon-6)	FACS		done

Back to list

CD44v3	Character	Application	Ref	Gene cloning	Company
anti-CD44v3 mAb (C44Mab-1080; mouse IgG1, kappa)	Mab6 for CD44v3	FACS, WB, IHC		done
anti-CD44v3 mAb (C44Mab-1006; mouse IgG1, kappa)	Mab11 for CD44v3	FACS, WB, IHC		done
CD44v5	Character	Application	Ref	Gene cloning	Company
anti-CD44v5 mAb (C44Mab-1088; mouse IgG1, kappa)	Mab8 for CD44v5	FACS, WB, IHC		done
anti-CD44v5 mAb (C44Mab-1003; mouse IgG1, kappa)	Mab12 for CD44v5	FACS, WB, IHC		done
CD44v6	Character	Application	Ref	Gene cloning	Company
anti-CD44v6 mAb (C44Mab-1074; mouse IgM, kappa)	V6CasMab-1 (IgM) for CD44v6	FACS, WB, IHC		done	restricted
anti-CD44v6 mAb (C44Mab-1079; mouse IgG1, kappa)	V6CasMab-2 for CD44v6	FACS, WB, IHC		done	restricted
anti-CD44v6 mAb (C44Mab-1081; mouse IgG1, kappa)	V6CasMab-3 for CD44v6	FACS, WB, IHC		done	restricted
anti-CD44v6 mAb (C44Mab-1089; mouse IgM, kappa)	V6CasMab-4 (IgM) for CD44v6	FACS, WB, IHC		done	restricted
anti-CD44v6 mAb (C44Mab-1092; mouse IgG3, kappa)	V6CasMab-5 (IgG3) for CD44v6	FACS, WB, IHC		done	restricted
CD44v6	Character	Application	Ref	Gene cloning	Company
anti-CD44v6 mAb (C44Mab-1074-mG1; mouse IgG1, kappa)	V6CasMab-1 for CD44v6	FACS, WB, IHC			restricted
anti-CD44v6 mAb (C44Mab-1089-mG1; mouse IgG1, kappa)	V6CasMab-4 for CD44v6	FACS, WB, IHC			restricted
anti-CD44v6 mAb (C44Mab-1092-mG1; mouse IgG1, kappa)	V6CasMab-5 for CD44v6	FACS, WB, IHC			restricted
CD44v7	Character	Application	Ref	Gene cloning	Company
anti-CD44v7 mAb (C44Mab-1030; mouse IgM, kappa)	Mab4 for CD44v7	FACS, WB, IHC		done
anti-CD44v7 mAb (C44Mab-1048; mouse IgG1, kappa)	Mab5 for CD44v7	FACS, WB, IHC		done
anti-CD44v7 mAb (C44Mab-1034; mouse IgG1, kappa)	Mab10 for CD44v7	FACS, WB, IHC		done

Back to list

EpCAM	Character	Application	Gene cloning
anti-EpCAM mAb (EpMab-1147; mouse IgG1, kappa)	Mab3 for EpCAM	FACS	done
anti-EpCAM mAb (EpMab-1007; mouse IgG1, kappa)	Mab4 for EpCAM	FACS	done
anti-EpCAM mAb (EpMab-1013; mouse IgG1, kappa)	Mab5 for EpCAM	FACS	done
anti-EpCAM mAb (EpMab-1022; mouse IgG1, kappa)	Mab6 for EpCAM	FACS	done
anti-EpCAM mAb (EpMab-1069; mouse IgG1, kappa)	Mab7 for EpCAM	FACS	done

Back to list

TROP2	Character	Application	Gene cloning
anti-TROP2 mAb (TrMab-1100; mouse IgG1, kappa)	Mab1 for human TROP2	FACS	done
anti-TROP2 mAb (TrMab-1148; mouse IgG1, kappa)	Mab3 for human TROP2	FACS	done
anti-TROP2 mAb (TrMab-1156; mouse IgG2b, kappa)	Mab4 for human TROP2	FACS	done

Back to list

EGFR	Character	Application	Gene cloning	Company
anti-EGFR mAb (ECasMab-1001; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1002; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1003; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1004; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1005; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1006; mouse IgM, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1007; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1008; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1009; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1010; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1011; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1012; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1013; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1014; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1015; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1016; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1017; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1018; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1019; mouse IgG1, kappa)	specific for EGFR	FACS	done	restricted
anti-EGFR mAb (ECasMab-1020; mouse IgM, kappa)	specific for EGFR	FACS	done	restricted

Back to list

HER2	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2CasMab-1; mouse IgG1,kappa)	H2Mab-214; specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC	H2Mab-214	done	restricted
anti-HER2 mAb (H2CasMab-2; mouse IgG1,kappa)	H2Mab-250; specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC	H2Mab-250 250_in vivo 250_CDC	done	restricted
anti-HER2 mAb (H2CasMab-3; mouse IgG3,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-4; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-5; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-6; mouse IgG2a,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-7; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-8; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-9; mouse IgG3,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-10; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-11; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-12; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-13; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-14; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-15; mouse IgG3,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-16; mouse IgG3,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-17; mouse IgG3,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-18; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-19; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-20; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-21; mouse IgG2a,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-22; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
anti-HER2 mAb (H2CasMab-23; mouse IgG1,kappa)	specific for HER2; domain-IV PCT/JP2021/043538	FACS, WB, IHC		done	restricted
HER2	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-250-mG2af; mouse IgG2a,kappa)	H2CasMab-2; specific for HER2; domain-IV	FACS, WB, IHC	H2Mab-250 250_in vivo 250_CDC	done	restricted
anti-HER2 mAb (H2Mab-250-hG1-f; human IgG1,kappa)	H2CasMab-2; specific for HER2; domain-IV	ADCC/CDC; antitumor activities	250_in vivo 250_CDC	done	restricted
anti-HER2 mAb (humH2Mab-250-f; human IgG1,kappa)	humanized H2Mab-250; H2CasMab-2; specific for HER2; domain-IV	ADCC/CDC; antitumor activities		done	restricted
anti-HER2 mAb (H2Mab-214-mG2af; mouse IgG2a,kappa)	H2CasMab-1; specific for HER2; domain-IV	FACS, WB, IHC	214-mG2a-f	done	restricted
anti-HER2 mAb (H2Mab-214-hG1; human IgG1,kappa)	H2CasMab-1; specific for HER2; domain-IV	FACS, WB, IHC		done	restricted

Back to list

HER3	Character	Application	Ref	Gene cloning	Company
anti HER3 mAb (H3Mab-1059; mouse IgG1,kappa)	Mab1 for HER3	FACS		done
anti HER3 mAb (H3Mab-1170; mouse IgG1,kappa)	Mab2 for HER3	FACS		done

Back to list

mCasMab

mouse EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (EMab-1302; rat IgG1, lambda)	crossreact with human EGFR; domain-I semi-candidate	FACS
anti-EGFR mAb (EMab-1303; rat IgM, kappa)	crossreact with human EGFR; domain-III candidate	FACS
anti-EGFR mAb (EMab-1304; rat IgG1, lambda)	crossreact with human EGFR; domain-I semi-candidate	FACS
mouse EGFR	Character	Application	Ref	Gene cloning	Company
anti-EGFR mAb (EMab-1303-mG1; mouse IgG1, kappa)	mouse IgG1 type of EMab-1303	FACS
anti-EGFR mAb (EMab-1303-mG2a; mouse IgG2a, kappa)	mouse IgG2a type of EMab-1303	FACS
anti-EGFR mAb (EMab-1303-hG1; human IgG1, kappa)	humna IgG1 type of EMab-1303	FACS

Back to list

mouse HER2	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-1301; rat IgG2a, lambda)	specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2	FACS		done
anti-HER2 mAb (H2Mab-1316; rat IgG2a, kappa)	specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2	FACS		done
anti-HER2 mAb (H2Mab-1319; rat IgG2a, kappa)	specific for mouse HER2; cross-react with HER2 (human; domiain-I); does not cross-react with dog HER2	FACS		done
mouse HER2 (CD340)	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2Mab-1301-hG1 ;human IgG1,kappa)	hIgG1 version of H2Mab-1301; cross-react with HER2 (human)	FACS		ongoing
anti-HER2 mAb (H2Mab-1316-hG1 ;human IgG1,kappa)	hIgG1 version of H2Mab-1316; cross-react with HER2 (human)	FACS		ongoing
anti-HER2 mAb (H2Mab-1319-hG1 ;human IgG1,kappa)	hIgG1 version of H2Mab-1319; cross-react with HER2 (human)	FACS		ongoing

Back to list

CAR-T

CD19 original	Character	Application	Ref	Gene cloning	Company
anti-CD19 mAb (C19Mab-2; mouse IgG1,kappa)	specific for CD19; CBIS method; LN229/CD19 immunization	FACS		done	restricted
CD19 humanized	Character	Application	Ref	Gene cloning	Company
anti-CD19 mAb (humC19Mab-2; human IgG1,kappa)	specific for CD19	FACS		done	restricted
CD19 scFv	Character	Application	Ref	Gene cloning	Company
anti-CD19 mAb (humC19Mab-2 -scFv)	scFv of humanized C19Mab-2	FACS		done	restricted

Back to list

GPC3 original	Character	Application	Ref	Gene cloning	Company
anti-GPC3 mAb (G3Mab-1; mouse IgG1, kappa)	specific for human GPC3 ref: abcam	FACS		done	restricted
anti-GPC3 mAb (G3Mab-2; mouse IgM, kappa)	specific for human GPC3	FACS, WB		done	restricted
anti-GPC3 mAb (G3Mab-3; mouse IgM, kappa)	specific for human GPC3	FACS, WB		done	restricted
GPC3 humanized	Character	Application	Ref	Gene cloning	Company
anti-GPC3 mAb (humG3Mab-1; human IgG1, kappa)	specific for human GPC3	FACS		done	restricted
anti-GPC3 mAb (humG3Mab-2; human IgG1, kappa)	specific for human GPC3	FACS		done	restricted
anti-GPC3 mAb (humG3Mab-3; human IgG1, kappa)	specific for human GPC3	FACS		done	restricted
GPC3 scFv	Character	Application	Ref	Gene cloning	Company
anti-GPC3 mAb (humG3Mab-1-scFv-Fc)	specific for human GPC3	CAR-T		done	restricted
anti-GPC3 mAb (humG3Mab-2-scFv-Fc)	specific for human GPC3	CAR-T		done	restricted
anti-GPC3 mAb (humG3Mab-3-scFv-Fc)	specific for human GPC3	CAR-T		done	restricted

Back to list

HER2 original	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2CasMab-2; mouse IgG1,kappa)	H2Mab-250; specific for HER2; domain-IV	FACS, WB, IHC	H2Mab-250 250_in vivo 250_CDC	done	restricted
HER2 scFv	Character	Application	Ref	Gene cloning	Company
anti-HER2 mAb (H2CasMab-2-scFv-Fc)	specific for HER2; domain-IV	CART	FT825	done	restricted

Back to list

PDPN original	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (LpMab-2; mouse IgG1, kappa)	CasMab	IHC, WB, FACS	Cells2022 LpMab-2 patent	done	restricted
anti-hPDPN mAb (LpMab-23; mouse IgG1, kappa)		IHC, WB, FACS	YouTube LpMab-23 IHC patent	done	restricted
anti-hPDPN mAb (PMab-117; rat IgM, kappa)		FACS	YouTube PMab-117-mG2a Cells2022 patent	done	restricted
PDPN humanized	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (humLpMab-23; human IgG1, kappa)		IHC, WB, FACS	YouTube humLpMab-23-f	done	restricted
anti-hPDPN mAb (humPMab-117; human IgG1, kappa)		FACS	YouTube	done	restricted
PDPN scFv	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (LpMab-2-scFv-Fc)	CasMab for human PDPN; scFv originated from LpMab-2	CART	LpMab-2-CART	done	restricted
anti-hPDPN mAb (humLpMab-23-scFv-Fc)	CasMab for human PDPN; scFv originated from LpMab-23	CART	YouTube	done	restricted
anti-hPDPN mAb (humPMab-117-scFv-Fc)	CasMab for human PDPN; scFv originated from PMab-117	CART	YouTube	done	restricted

Back to list

Podocalyxin original	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb (PcMab-6; mouse IgG1, kappa)	anti-PODXL CasMab	FACS	PcMab-6 patent	done	restricted
Podocalyxin humanized	Character	Application	Ref	Gene cloning	Company
anti-PODXL mAb (humPcMab-6; human IgG1, kappa)	anti-PODXL CasMab	FACS	humPcMab-6-f	done	restricted
Podocalyxin scFv	Character	Application	Ref	Gene cloning	Company
anti-hPDPN mAb (humPcMab-6-scFv; scFv)	CasMab; scFv originated from PcMab-6	CART	submit	done	restricted

Back to list

Company (clone) --> mAb list (target)

Abcam
AMab-6/ C44Mab-5/ CMab-43/ EMab-134/ GMab-r1/ H2Mab-139/ HMab-2/ KMab-1/ LpMab-7/ MMab-1/ MsMab-1/ PMab-1/ PcMab-47/ RcMab-1/ SMab-1/ WMab-1
Absolute antibody
PMab-1/ PMab-2/ PMab-292/ PMab-295
APRO (PFI)
AMab-6/ HisMab-1/ HMab-1/ HMab-2/ LpMab-12/ NZ-1/ PMab-1/ PMab-2/ PMab-44/ PcMab-47/ TMab-2
BD
C2Mab-6/ C3Mab-4 (C3Mab-6, C3Mab-7)/ C6Mab-9/ C39Mab-1 (C39Mab-2)/ C44Mab-6/ C44Mab-9/ Cx6Mab-1/ CMab-43/ H2Mab-303 (H2Mab-304, H2Mab-307)/ EMab-134/ EMab-300/ LpMab-17/ LpMab-23/ NZ-1/ PMab-1/ RMab-3/ TgMab-2
BioLegend
C20Mab-60/ C44Mab-5/ KrMab-3/ LpMab-21/ PMab-1/ PMab-2/ YM-2
CST
C44Mab-3/ C44Mab-9/ C44Mab-108/ KrMab-3/ LpMab-12/ RcMab-1
Exbio
C9Mab-1/ H3Mab-17/ LpMab-23/ PcMab-47/ TrMab-6
FUJIFILM WAKO
AMab-6/ CMab-43/ EMab-134/ HMab-1/ HMab-2/ MsMab-1/ NZ-1/ NZ-1.2/ PMab-1/ PMab-38/ PcMab-47/ RMab-22/ SMab-1/ TMab-6
Hycult
LpMab-12/ LpMab-13/ LpMab-17
IBL
HMab-1/ SMab-1
MCP
LpMab-3/ LpMab-7/ LpMab-9/ LpMab-12/ LpMab-21
MBL
GMab-r1/ HMab-1/ KMab-1/ KrMab-3/ MMab-1/ MsMab-2/ NZ-1.2/ PMab-1/ RcMab-1/ RMab-3/ SMab-1/ WMab-1
Merck
C8Mab-2/ C44Mab-3/ C44Mab-9/ C44Mab-108/ EpMab-16/ G4B1/ HMab-1/ LpMab-12/ LpMab-13/ LpMab-17/ LpMab-21/ MsMab-1/ NZ-1.2/ PMab-1/ PMab-2/ RMab-3/ RMab-22/ SMab-1/ t8E4/ TpMab-3/ TrMab-29/ TwMab-1
Novus
NZ-1.2/ PMab-1
Zenogen
LpMab-7/ LpMab-12/ PMab-38/ PMab-44/ PMab-48/ PMab-52/ PMab-202/ PMab-210/ PMab-213/ PMab-219/ PMab-225/ PMab-231/ PMab-233/ PMab-235/ PMab-237/ PMab-247/ PMab-256/ NZ-1.2

Back to list

Antibody Bank(Kato's Lab; Tohoku University)

Antibody Bank
(Kato's Lab; Tohoku University)